L1| carelon.com
L2| Status:  Revised        Effective Date:  11/05/2023
L3| Doc ID: MSK0 2-1123.1         Last Review Date:  04/12/2023
L4| Approval and implementation dates for specific health plans may vary. Please consult the applicable health plan for more details.
L5| Clinical Appropriateness Guidelines
L6| Musculoskeletal
L7| Appropriate Use Criteria:
L8| Joint Surgery
L9| Proprietary
L10| © 2023 Carelon Medical Benefits Management, Inc. All rights reserved.
L11| Joint Surgery
L12| © 2023 Carelon Medical Benefits Management. All rights reserved .  2 Table of Contents
L13| Description and Application of the Guideli nes ................................ ................................ ................................ ..............................  4
L14| General Clinical Guideline  ................................ ................................ ................................ ................................ ............................  5
L15| Shoulder Arthroplasty (Total/Partial/Revision Shoulder Replacement)  ................................ ................................ ........................  7
L16| Description and Scope  ................................ ................................ ................................ ................................ .............................  7
L17| Clinical Indications  ................................ ................................ ................................ ................................ ................................ ... 7
L18| Contraindications  ................................ ................................ ................................ ................................ ................................ ... 10
L19| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  11
L20| Selected References  ................................ ................................ ................................ ................................ ..............................  11
L21| Codes  ................................ ................................ ................................ ................................ ................................ ....................  11
L22| Shoulder Arthroscopy and Open Procedures  ................................ ................................ ................................ .............................  12
L23| Description and Scope  ................................ ................................ ................................ ................................ ...........................  12
L24| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 12
L25| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  19
L26| Selected References  ................................ ................................ ................................ ................................ ..............................  19
L27| Codes  ................................ ................................ ................................ ................................ ................................ ....................  20
L28| Hip Arthroplasty (Total/Partial/Revision Hip Replacement , Acetabuloplasty, Resection Arthroplasty)  ................................ ....... 22
L29| Description and Scope  ................................ ................................ ................................ ................................ ...........................  22
L30| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 22
L31| Contraindications  ................................ ................................ ................................ ................................ ................................ ... 26
L32| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  26
L33| Selected Ref erences  ................................ ................................ ................................ ................................ ..............................  27
L34| Codes  ................................ ................................ ................................ ................................ ................................ ....................  27
L35| Hip Arthroscopy  ................................ ................................ ................................ ................................ ................................ ..........  28
L36| Description and Scope  ................................ ................................ ................................ ................................ ...........................  28
L37| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 28
L38| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  32
L39| Selected References  ................................ ................................ ................................ ................................ ..............................  32
L40| Codes  ................................ ................................ ................................ ................................ ................................ ....................  33
L41| Knee Arthroplasty (Total/Partial/Revision Knee Replace ment)  ................................ ................................ ................................ .. 34
L42| Description and Scope  ................................ ................................ ................................ ................................ ...........................  34
L43| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 34
L44| Contraindications  ................................ ................................ ................................ ................................ ................................ ... 38
L45| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  38
L46| Selected References  ................................ ................................ ................................ ................................ ..............................  39
L47| Codes  ................................ ................................ ................................ ................................ ................................ ....................  39
L48| Knee Arthroscopy and Open Procedures  ................................ ................................ ................................ ................................ ... 40
L49| Description and Scope  ................................ ................................ ................................ ................................ ...........................  40
L50| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 40
L51| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  48
L52| Selected References  ................................ ................................ ................................ ................................ ..............................  48
L53| Joint Surgery
L54| © 2023 Carelon Medical Benefits Management. All rights reserved .  3 Codes  ................................ ................................ ................................ ................................ ................................ ....................  48
L55| Meniscal Allograft Transplantation of the Knee  ................................ ................................ ................................ ..........................  51
L56| Description  ................................ ................................ ................................ ................................ ................................ .............  51
L57| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 51
L58| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  52
L59| Selected References  ................................ ................................ ................................ ................................ ..............................  52
L60| Codes  ................................ ................................ ................................ ................................ ................................ ....................  53
L61| Osteochondral Grafts  ................................ ................................ ................................ ................................ ................................ . 54
L62| Description and Scope  ................................ ................................ ................................ ................................ ...........................  54
L63| Clinical Indications  ................................ ................................ ................................ ................................ ................................ . 54
L64| Contraindications  ................................ ................................ ................................ ................................ ................................ ... 58
L65| Exclusions  ................................ ................................ ................................ ................................ ................................ ..............  58
L66| Selected References  ................................ ................................ ................................ ................................ ..............................  59
L67| Codes  ................................ ................................ ................................ ................................ ................................ ....................  59
L68| Appendix  ................................ ................................ ................................ ................................ ................................ ....................  60
L69| History  ................................ ................................ ................................ ................................ ................................ ........................  61
L70| Joint Surgery
L71| © 2023 Carelon Medical Benefits Management. All rights reserved .  4 Description and Application of the Guidelines
L72| The Carelon Clinical Appropriateness Guidelines (hereinafter “the Carelon Clinical Appropria teness Guidelines” or
L73| the “Guidelines”) are designed to assist providers in making the most appropriate treatment decision for a specific
L74| clinical condition for an individual. As used by Carelon, the Guidelines establish objective and evidence -based
L75| criter ia for medical necessity determinations where possible. In the process, multiple functions are accomplished:
L76| • To establish criteria for when services are medically necessary (i.e., in general, shown to be effective in
L77| improving health outcomes and considere d the most appropriate level of service)
L78| • To assist the practitioner as an educational tool
L79| • To encourage standardization of  medical practice patterns
L80| • To curtail the performance of  inappropriate and/or duplicate services
L81| • To advocate for  patient safety  concerns
L82| • To enhance the quality of  health care
L83| • To promote the most efficient and cost -effective use of services
L84| The Carelon guideline development process complies with applicable accreditation standards, including the
L85| requirement that the Guidelines be developed with involvement from appropriate providers with current clinical
L86| expertise relevant to the Guidelines under review and be based on the most up -to-date clinical principles and best
L87| practices.  Relevant citations are included in the R eferences section attached to each Guideline.  Carelon reviews
L88| all of its Guidelines at least annuall y.
L89| Carelon makes its Guidelines publicly available on its website twenty -four hours a day, seven days a week.
L90| Copies of the Carelon Clinical Appropriateness  Guidelines are also available upon oral or written request.
L91| Although the Guidelines are publicly -available, Carelon considers the Guidelines to be important, proprietary
L92| information of Carelon, which cannot be sold, assigned, leased, licensed, reproduced or distributed without the
L93| written consent of Carelon.
L94| Carelon applies objective and evidence -based criteria, and takes individual circumstances and the local delivery
L95| system into account when determining the medical appropriateness of health care services . The Carelon
L96| Guidelines are just guidelines for the provision of specialty health services. These criteria are designed to guide
L97| both providers and reviewers to the most appropriate services based on a patient’s unique circumstances. In all
L98| cases, clinica l judgment consistent with the standards of good medical practice should be used when applying the
L99| Guidelines. Guideline determinations are made based on the information provided at the time of the request. It is
L100| expected that medical necessity decisions m ay change as new information is provided or based on unique
L101| aspects of the patient’s condition. The treating clinician has final authority and responsibility for treatment
L102| decisions regarding the care of the patient and for justifying and demonstrating the  existence of medical necessity
L103| for the requested service. The Guidelines are not a substitute for the experience and judgment of a physician or
L104| other health care professionals. Any clinician seeking to apply or consult the Guidelines is expected to use
L105| independent medical judgment in the context of individual clinical circumstances to determine any patient’s care
L106| or treatment.
L107| The Guidelines do not address coverage, benefit or other plan specific issues. Applicable federal and state
L108| coverage mandates take precedence over these clinical guidelines. If requested by a health plan, Carelon will
L109| review requests based on health plan medical policy/guidelines in lieu of the Carelon Guidelines.
L110| Pharmaceuticals, radiotracers, or medical devices used in any of the di agnostic or therapeutic interventions listed
L111| in the Guidelines must be FDA approved or conditionally approved for the intended use. However, use of an FDA
L112| approved or conditionally approved product does not constitute medical necessity or guarantee reimbur sement by
L113| the respective health plan.
L114| The Guidelines may also be used by the health plan or by Carelon for purposes of provider education, or to
L115| review the medical necessity of services by any provider who has been notified of the need for medical necessit y
L116| review, due to billing practices or claims that are not consistent with other providers in terms of frequency or some
L117| other manner.
L118| Joint Surgery
L119| © 2023 Carelon Medical Benefits Management. All rights reserved .  5 General Clinical Guideline
L120| Clinical Appropriateness Framework
L121| Critical to any finding of clinical appropriateness under the guidelines for a specific diagnostic or therapeutic
L122| intervention are the following elements:
L123| • Prior to any intervention, it is essential that the clinician confirm the diagnosis or establish its pretest
L124| likelihood based on a complete evaluation of the p atient. This includes a history and physical examination
L125| and, where applicable, a review of relevant laboratory studies, diagnostic testing, and response to prior
L126| therapeutic intervention.
L127| • The anticipated benefit of the recommended intervention should outw eigh any potential harms that may
L128| result (net benefit).
L129| • Current literature and/or standards of medical practice should support that the recommended intervention
L130| offers the greatest net benefit among competing alternatives.
L131| • Based on the clinical evaluation , current literature, and standards of medical practice, there exists a
L132| reasonable likelihood that the intervention will change management and/or lead to an improved outcome
L133| for the patient.
L134| If these elements are not established with respect to a given req uest, the determination of appropriateness will
L135| most likely require a peer -to-peer conversation to understand the individual and unique facts that would
L136| supersede the requirements set forth above. During the peer -to-peer conversation, factors such as patie nt acuity
L137| and setting of service may also be taken into account.
L138| Simultaneous Ordering of Multiple Diagnostic or Therapeutic Interventions
L139| Requests for multiple diagnostic or therapeutic interventions at the same time will often require a peer -to-peer
L140| conversation to understand the individual circumstances that support the medical necessity of performing all
L141| interventions simultaneously. This is based on the fact that appropriateness of additional intervention is often
L142| dependent on the outcome of the initi al intervention.
L143| Additionally, either of the following may apply:
L144| • Current literature and/or standards of medical practice support that one of the requested diagnostic or
L145| therapeutic interventions is more appropriate in the clinical situation presented; or
L146| • One of the diagnostic or therapeutic interventions requested is more likely to improve patient outcomes
L147| based on current literature and/or standards of medical practice.
L148| Repeat Diagnostic Intervention
L149| In general, repeated testing of the same anatomic loca tion for the same indication should be limited to evaluation
L150| following an intervention, or when there is a change in clinical status such that additional testing is required to
L151| determine next steps in management. At times, it may be necessary to repeat a t est using different techniques or
L152| protocols to clarify a finding or result of the original study.
L153| Repeated testing for the same indication using the same or similar technology may be subject to additional review
L154| or require peer -to-peer conversation in the following scenarios:
L155| • Repeated diagnostic testing at the same facility due to technical issues
L156| • Repeated diagnostic testing requested at a different facility due to provider preference or quality
L157| concerns
L158| • Repeated diagnostic testing of the same anatomic area based on persistent symptoms with no clinical
L159| change, treatment, or intervention since the previ ous study
L160| Joint Surgery
L161| © 2023 Carelon Medical Benefits Management. All rights reserved .  6 • Repeated diagnostic testing of the same anatomic area by different providers for the same member over
L162| a short period of time
L163| Repeat Therapeutic Intervention
L164| In general, repeated therapeutic intervention in the same anatomic area is considered app ropriate when the prior
L165| intervention proved effective or beneficial and the expected duration of relief has lapsed. A repeat intervention
L166| requested prior to the expected duration of relief is not appropriate unless it can be confirmed that the prior
L167| interv ention was never administered.
L168| Joint Surgery
L169| © 2023 Carelon Medical Benefits Management. All rights reserved .  7 Shoulder Arthroplasty (Total/Partial/Revision Shoulder
L170| Replacement)
L171| Description and Scope
L172| Shoulder arthroplasty includes several procedures to replace components of the shoulder joint, in part or in total,
L173| with the goal of  improving function and reducing pain. Prosthetic replacement of the humeral head and the
L174| glenoid (total arthroplasty) is most commonly performed for joint damage due to osteoarthritis. Total shoulder
L175| arthroplasty requires an intact medial glenoid to suppo rt the glenoid prosthesis.
L176| Shoulder hemiarthroplasty (partial replacement) may be used to address isolated humeral head pathology
L177| (avascular necrosis), some fractures, or as an option for rotator cuff tear arthropathy.
L178| Reverse total shoulder arthroplasty  is similar to standard arthroplasty in that both components of the joint are
L179| replaced but the ball and socket portions of the joint are reversed, allowing the deltoid muscle to assume partial
L180| function of the rotator cuff. This procedure is typically utili zed when there is concomitant rotator cuff disease.
L181| This guideline addresses shoulder arthroplasty when performed as an elective, non -emergent  procedure and
L182| not as part of the care of a congenital condition, acute or traumatic event such as fracture (excl uding fracture of
L183| implant and periprosthetic fracture).
L184| All shoulder arthroplasties are inclusive of the reattachment of any muscles divided for access to the shoulder,
L185| accompanying excision of osteophytes, acromioplasty, synovectomy and shoulder arthroto my with associated
L186| removal of debris.
L187| Clinical Indications
L188| The following general requirements apply to all indications except where they differ from the specific
L189| requirements. The specific requirements take precedence over any stated general requirement.
L190| General Information
L191| The terms in the section provide operational definitions when they are referenced as requirements in the
L192| guideline.
L193| Documentation supporting medical necessity and a clearly stated plan of care should be submitted at the time of
L194| the reque st and must include the following components:
L195| Clinical notes  describing symptom duration and severity, specific functional limitations related to symptoms, and
L196| type and duration of all therapeutic measures provided. If conservative management is not appro priate, the
L197| reason must be clearly documented.
L198| Conservative management1 must include a combination of strategies to reduce inflammation, alleviate pain, and
L199| correct underlying dysfunction, including physical therapy AND  at least ONE  complementary conservat ive
L200| treatment strategy.
L201| • Physical therapy requirement  includes ANY  of the following:
L202| o Physical therapy rendered by a qualified provider of physical therapy services
L203| o Supervised home treatment program that includes  ALL of the following:
L204| ▪ Participation in a patient -specific or tailored program
L205| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ability to perform
L206| exercises
L207| ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L208| Joint Surgery
L209| © 2023 Carelon Medical Benefits Management. All rights reserved .  8 o Exception to the physica l therapy requirement in unusual circumstances (for instance,
L210| intractable pain so severe that physical therapy is not possible) when clearly documented in the
L211| medical record
L212| • Complementary conservative treatment requirement  includes ANY  of the following:
L213| o Anti-inflammatory medications and analgesics2
L214| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L215| o Intra-articular corticosteroid injection(s)2
L216| o Alternative therapies such as activity modification, and/or a trial period of rest (e. g., from the
L217| aggravating/contributing factors), where applicable
L218| 1 Additional condition or procedure -specific requirements may apply and can be found in the respective sections
L219| of the guideline.
L220| 2 In the absence of contraindications
L221| Clinical reevaluation . In most cases, reevaluation should include a physical examination. Direct contact by other
L222| methods, such as telephone communication or electronic messaging, may substitute for in -person evaluation
L223| when circumstances preclude an office visit. Clinical reev aluation must be done in reasonable proximity to the
L224| anticipated date of service such that the patient’s condition would be unlikely to change by the date of service.
L225| Failure of conservative management requires ALL of the following:
L226| • Patient has completed a  full course of conservative management (as defined above) for the current
L227| episode of care
L228| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L229| • More invasive forms of therapy are being considered
L230| Documentation of compliance with a plan of therapy that includes elements from these areas is required where
L231| conservative management is appropriate.
L232| Reporting symptom severity . Severity of pain and its associated impact on activities of daily living (ADLs) and
L233| instrumental  ADLs (IADLs) are key factors in determining the need for intervention. For purposes of this guideline,
L234| significant pain and functional impairment refer to pain rated at least 3 out of 10 in intensity and associated with
L235| inability to perform at least two ( 2) ADLs and/or IADLs.
L236| Imaging reports  obtained within the past 12 months describing the degree of cartilage damage as determined by
L237| either or both of the following methods:
L238| • X-ray report or provider interpretation of x -rays that utilizes or can be correlat ed with the Kellgren -
L239| Lawrence grading system of osteoarthritis
L240| • MRI report from a radiologist that utilizes or can be correlated with the modified Outerbridge or similar
L241| classification system related to articular cartilage injury and osteoarthritis
L242| See Appendix  for a description of these grading systems.
L243| For x -ray interpretation, t he provider shall submit a detailed imaging description that correlates with clinical
L244| findings of the requested procedure. In the absence of a detailed description , the provider may submit a report
L245| from an independent radiologist. The results of all imaging studies should correlate with the clinical findings in
L246| support of the requested procedure.
L247| For advanced imaging (CT, MRI, ultrasound, bone scan), there must be a report from a radiologist that correlates
L248| with clinical findings. In the absence of such a report, the summary findings from the radiology report  should be
L249| included  in the clinical records.
L250| Imaging reports should be thorough and describe the presence or absence of subchondral cysts, subchondral
L251| sclerosis, periarticular osteophytes, joint subluxation, avascular necrosis , or bone on bone articulations.  The
L252| degree of joint space narrowing should also be noted.
L253| Joint Surgery
L254| © 2023 Carelon Medical Benefits Management. All rights reserved .  9 General Recommendations
L255| Tobacco cessation . Adherence to a tobacco cessation program resulting in abstinence from tobacco for at least
L256| 6 weeks prior to surgery is strongly recommended.
L257| Diabetes . It is strongly recommended that a patient with a history of diabetes maintain a hemoglobin A1C of 8%
L258| or less prior to any joint replacement surgery.
L259| Body mass index (BMI) . It is strongly recommended that a patient with a BMI equal to or greater than 40 att empt
L260| weight reduction prior to surgery.
L261| Where there are patient specific modifiable comorbidities that may adversely impact patient reported outcomes or
L262| the health status of the patient a shared decision -making process with the patient to discuss these mod ifiable
L263| comorbidities is strongly recommended and should be documented.
L264| Specific Requirements
L265| ALL of the following conditions must be present regardless of indication for which the procedure is being
L266| performed:
L267| • Anticipated level of function should place l imited demands on the shoulder joint
L268| • Deltoid muscle must be intact
L269| • Shoulder joint must be anatomically and structurally suited to receive selected implants (i.e., adequate
L270| bone stock to allow for firm fixation of implant)
L271| Total Shoulder Arthroplasty
L272| Tota l shoulder arthroplasty is considered medically necessary for ANY of the following indications:
L273| • Proximal humerus fracture not amenable to internal fixation
L274| • Malignancy involving the glenohumeral joint or surrounding soft tissue
L275| • Advanced joint disease of th e shoulder due to osteoarthritis rheumatoid arthritis, avascular necrosis
L276| (osteonecrosis) , or post -traumatic arthritis when ALL of the following requirements are met:
L277| o Limited range of motion or crepitus of the glenohumeral joint on physical examination
L278| o Pain and loss of function of at least 6 months’ duration that interferes with daily activities
L279| o Radiographic evidence of destructive degenerative joint disease as evidenced by 2 or more of the
L280| following:
L281| ▪ Irregular joint surfaces
L282| ▪ Glenoid sclerosis
L283| ▪ Osteophyt e changes
L284| ▪ Flattened glenoid
L285| ▪ Cystic changes in the humeral head
L286| ▪ Joint space narrowing
L287| o Failure of conservative management of at least 6 weeks’ duration  (unless radiographs show
L288| Kellgren -Lawence grade 4)
L289| Hemiarthroplasty
L290| Hemiarthroplasty is considered medically necessary for ANY of the following indications:
L291| • Proximal humerus fracture not amenable to internal fixation
L292| Joint Surgery
L293| © 2023 Carelon Medical Benefits Management. All rights reserved .  10 • Malignancy involving the glenohumeral joint or surrounding soft tissue
L294| • Advanced joint disease of the shou lder when criteria for total shoulder arthroplasty  are met  AND at least
L295| ONE of the following conditions is present:
L296| o Osteonecrosis of the humeral head without glenoid involvement
L297| o Advanced joint disease due to rotator cuff tear arthropathy
L298| o Glenoid bone stock inadequate t o support a glenoid prosthesis
L299| o Glenohumeral osteoarthritis with irreparable rotator cuff tear
L300| Reverse Shoulder Arthroplasty
L301| Reverse shoulder arthroplasty is considered medically necessary for ANY of the following indications:
L302| • Reconstruction after a tumor resection
L303| • Glenohumeral osteoarthritis with irreparable rotator cuff tear
L304| • Glenoid bone stock inadequate to support a glenoid prosthesis
L305| • Failed hemiarthroplasty
L306| • Failed total shoulder arthroplasty with non -repairable rotator cuff
L307| • Shoulder fracture that is not  repairable or cannot be reconstructed with other techniques
L308| • Advanced joint disease of the shoulder when criteria for total shoulder arthroplasty  are met  AND the
L309| following co ndition is present:
L310| o Deficient rotator cuff with limited ability to actively flex the upper extremity to 90 degrees against
L311| gravity
L312| Revision or Replacement of a Shoulder Prosthesis
L313| Revision or replacement of a shoulder prosthesis is considered medically nec essary for ANY of the
L314| following conditions when associated with pain and functional impairment:
L315| • Aseptic loosening of one or more prosthetic components confirmed by imaging
L316| • Fracture of one or more components of the prosthesis confirmed by imaging
L317| • Reconstruction after the management of p eriprosthetic infection confirmed by gram stain and culture
L318| • Instability of the glenoid or humeral components
L319| • Migration of the humeral head
L320| Contraindications
L321| All arthroplasty procedures
L322| • Active infection of the joint
L323| • Active systemic bacteremia
L324| • Active skin infection (exception recurrent cutaneous staph infections) or open wound within the planned
L325| surgical site of the shoulder
L326| • Rapidly progressive neurologic disease
L327| • Intra-articular corticosteroid injection within the p ast 6 weeks in the joint being replaced
L328| Joint Surgery
L329| © 2023 Carelon Medical Benefits Management. All rights reserved .  11 Exclusions
L330| Indications other than those addressed in this guideline are considered not medically necessary  including, but
L331| not limited to, the following:
L332| • Total shoulder arthroplasty or hemiarthroplasty under condition s which would result in excessive stress
L333| on the implant including, but not limited to, Charcot joint and paralytic conditions of the shoulder
L334| • Shoulder resurfacing, including total, hemi, or partial resurfacing  (e.g., Copeland ™, the Extended
L335| Articulating S urface (EAS) ™ Resurfacing Heads, Global CAP ™ CTA Resurfacing Shoulder Humeral
L336| Head)
L337| Selected References
L338| 1. Carter MJ, Mikuls TR, Nayak S, Fehringer EV, Michaud K. Impact of total shoulder arthroplasty on generic and shoulder -specific
L339| health -related quality -of-life measures: a systematic literature review and meta -analysis. J Bone Joint Surg Am.
L340| 2012;94(17):e127.
L341| 2. Craig RS, Goodier H, Singh JA, Hopewell S, Rees JL. Shoulder replacement surgery for osteoarthritis and rotator cuff tear
L342| arthropathy. Cochrane Databa se Syst Rev. 2020;4(4):Cd012879.
L343| 3. Khan WS, Longo UG, Ahrens PM, Denaro V, Maffulli N. A systematic review of the reverse shoulder replacement in rotator cuff
L344| arthropathy, rotator cuff tears, and rheumatoid arthritis. Sports Med Arthrosc Rev. 2011;19(4):366 -79.
L345| 4. Khazzam M, Gee AO, Pearl M. Management of Glenohumeral Joint Osteoarthritis. J Am Acad Orthop Surg. 2020;28(19):781 -9.
L346| 5. Rasmussen JV. Outcome and risk of revision following shoulder replacement in patients with glenohumeral osteoarthritis. Acta
L347| Orthop S uppl. 2014;85(355):1 -23.
L348| Codes
L349| The following code list is not meant to be all -inclusive. Authorization requirements will vary by health plan. Please consult the
L350| applicable health plan for guidance on specific procedure codes.
L351| Specific CPT codes for service s should be used when available. Nonspecific or not otherwise classified codes may be subject
L352| to additional documentation requirements and review.
L353| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must acc urately
L354| identify the service or procedure to be performed. If no such code exists, contact the health plan directly and report the se rvice
L355| or procedure using the appropriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in 99) . Do
L356| not submit a code that is “close to” the procedure performed in lieu of an unlisted code. Correct coding demands that the cod e
L357| reported is appropriate for the service provided (i.e., a code that most accurately represents the service provided), and no t a
L358| code that is similar but represents another service. ( CPT® Assistant , December 2010)
L359| CPT/HCPCS
L360| CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five-digit codes,
L361| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L362| practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herei n.
L363| 23470  Arthroplasty, glenohumeral joint; hemiarthroplasty
L364| 23472  Arthroplasty, glenohumeral joint; total shoulder (glen oid and proximal humeral replacement (eg, total shoulder))
L365| 23473  Revision of total shoulder arthroplasty, including allograft when performed; humeral or glenoid component
L366| 23474  Revision of total shoulder arthroplasty, including allograft when performed; humeral and glenoid component
L367| Joint Surgery
L368| © 2023 Carelon Medical Benefits Management. All rights reserved .  12 Shoulder Arthroscopy and Open Procedures
L369| Description and Scope
L370| Arthroscopy is a surgical procedure in which a small fiberoptic camera is inserted into the joint through a small
L371| incision. In addition to allowing the surgeon  to visualize the joint, arthroscopy may also be utilized for treatment of
L372| a variety of conditions involving the joint structures.
L373| This guideline addresses shoulder arthroscopy and open procedures when performed as an elective, non -
L374| emergent procedure  and not as part of the care of an acute fracture.
L375| All arthroscopic procedures of the shoulder are inclusive of diagnostic arthroscopy and manipulation under
L376| anesthesia.
L377| All open procedures of the shoulder are inclusive of manipulation under anesthesia. Open rotator cuff repair
L378| procedures are inclusive of diagnostic arthroscopy.
L379| Clinical Indications
L380| The following general requirements apply to all indications except where they differ from the specific
L381| requirements. The specific requirements tak e precedence over any stated general requirement.
L382| General Information
L383| The terms in the section provide operational definitions when they are referenced as requirements in the
L384| guideline.
L385| Documentation supporting medical necessity and a clearly stated plan of care should be submitted at the time of
L386| the request and must include the following components:
L387| Imaging report . The provider shall submit a detailed imaging report for studies obtained within the past 12
L388| months . In the absence of a detailed report, the  provider may submit a report from an independent radiologist.
L389| The results of all imaging studies should correlate with the clinical findings in support of the requested procedure.
L390| For x -ray interpretation, the provider shall submit a detailed imaging des cription that correlates with clinical
L391| findings of the requested procedure. In the absence of a detailed description, the provider may submit a
L392| radiologist’s report.
L393| For advanced imaging (CT, MRI, ultrasound, bone scan), there must be a report from a radiologist that correlates
L394| with clinical findings. In the absence of such a report, the summary findings from the radiology report should be
L395| included in the clinical reco rds.
L396| Conservative management . In the majority of cases, a period of conservative management is appropriate prior
L397| to intervention. Conservative management1 must include a combination of strategies to reduce inflammation,
L398| alleviate pain, and correct underlyi ng dysfunction, including physical therapy AND  at least ONE  complementary
L399| conservative treatment strategy.
L400| • Physical therapy requirement  includes ANY  of the following:
L401| o Physical therapy rendered by a qualified provider of physical therapy services
L402| o Supervise d home treatment program that includes ALL of the following:
L403| ▪ Participation in a patient -specific or tailored program
L404| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ability to perform
L405| exercises
L406| ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L407| Joint Surgery
L408| © 2023 Carelon Medical Benefits Management. All rights reserved .  13 o Exception to the physical therapy requirement in unusual circumstances (for instance,
L409| intractable pain so severe that physical therapy is not possible) when clearly documented in the
L410| medical record
L411| • Complementary conser vative treatment requirement  includes ANY  of the following:
L412| o Anti-inflammatory medications and analgesics2
L413| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L414| o Intra-articular corticosteroid injection(s)2
L415| o Alternative therapies suc h as activity modification, and/or a trial period of rest (e.g., from the
L416| aggravating/contributing factors), where applicable
L417| 1 Additional condition or procedure -specific requirements may apply and can be found in the respective sections
L418| of the guideline.
L419| 2 In the absence of contraindications
L420| Clinical reevaluation . In most cases, reevaluation should include a physical examination. Direct contact by other
L421| methods, such as telephone communication or electronic messaging, may substitute for in -person evaluatio n
L422| when circumstances preclude an office visit.  Clinical reevaluation should be done in reasonable proximity to the
L423| anticipated date of service  such that the patient’s condition would be unlikely to change by the date of service .
L424| Failure of conservative ma nagement  requires ALL of the following:
L425| • Patient has completed a full course of conservative management (as defined above) for the current
L426| episode of care
L427| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L428| • More i nvasive forms of therapy are being considered
L429| Documentation of compliance with a plan of therapy that includes elements from these areas is required where
L430| conservative management is appropriate.
L431| Reporting severity reporting . Severity of pain and its assoc iated impact on activities of daily living (ADLs) and
L432| instrumental ADLs (IADLs) are key factors in determining the need for intervention. For purposes of this guideline,
L433| significant pain and functional impairment refer to pain rated at least 3 out of 10 in  intensity and associated with
L434| inability to perform at least two (2) ADLs and/or IADLs.
L435| Shoulder Arthroscopy
L436| Diagnostic arthroscopy
L437| Diagnostic arthroscopy of the shoulder joint is considered medically necessary for synovial biopsy or tissue
L438| harvest (chondrocyte), or when the involved joint meets ALL of the following criteria:
L439| • Presence of ONE  of the following symptoms
L440| o Significant pain and functional limitation
L441| o Instability (e.g., giving way, catching, clicking, locking)
L442| o Limited range of motion
L443| • Presence of ONE  of the following physical exam findings
L444| o Limited range of motion
L445| o Joint swelling
L446| o Inconclusive specific diagnostic exam maneuvers
L447| o Local muscle weakness or atrophy
L448| Joint Surgery
L449| © 2023 Carelon Medical Benefits Management. All rights reserved .  14 o Inconclusive x -ray and/or advanced imaging studies
L450| o Failure of at least 6 weeks of conservative management
L451| Exclusion
L452| In-office diagnostic arthroscopy (e.g., mi -eye 2®)
L453| Removal of loose body
L454| Removal of loose body  is considered medically necessary when  BOTH  of the following are present:
L455| • Radiographic evidence of acute, post -traumatic, intra -articular foreign body or displaced fracture fragment
L456| larger than the size of an arthroscopy cannula (5 mm or larger)
L457| • Shoulder pa in associated with grinding, catching, locking , or popping , and exam findings confirm pain
L458| with limited range of motion
L459| Exclusion
L460| Removal of loose body  for Kellgren -Lawrence grade 4 osteoarthritis
L461| Rotator Cuff Repair
L462| Tobacco cessation . For primary rotator  cuff repair, a dherence to a tobacco cessation program resulting in
L463| abstinence from tobacco for at least 6 weeks prior to surgery is strongly recommended.
L464| Acute full thickness tear
L465| Rotator cuff repair  is considered medically necessary for an acute full thickness tear when ALL of the following
L466| criteria are met:
L467| • Traumatic injury within the preceding 3 months with no preexisting shoulder pain  (For traumatic injuries
L468| that occurred more than 3 months ago, se e chronic or degenerative full thickness tear )
L469| • Shoulder pain ≥ 4 on the VAS scale exacerbated by movement
L470| • Weakness of rotator cuff muscle(s)
L471| • Physical exam demonstrating a positi ve response to at least ONE  of the following tests:
L472| o Drop arm test
L473| o Painful arc test
L474| o Full/empty can test
L475| o Weakness of external /internal  rotation
L476| • Advanced imaging confirms features of an acute full thickness or high -grade partial tear
L477| Chronic or degenerative  full thickness tear
L478| Rotator cuff repair  is considered medically necessary for a chronic or degenerative full thickness tear when ALL
L479| of the following criteria are met:
L480| • Gradual onset of shoulder pain in the absence of a significant traumatic event  within t he preceding  3
L481| months
L482| • Pain ≥ 4 on the VAS scale which interferes with age -appropriate activities of daily living
L483| • Weakness of rotator cuff muscle(s)
L484| • Physical exam demonstrating a positive response to at least ONE  of the following tests:
L485| o Drop arm test
L486| Joint Surgery
L487| © 2023 Carelon Medical Benefits Management. All rights reserved .  15 o Painful arc test
L488| o Full/empty can test
L489| o Weakness of external /internal  rotation  or abduction
L490| • Recent advanced imaging confirms features of a degenerative full  thickness tear
L491| • Failure of at least 6 weeks of conservative management
L492| Partial thickness tear
L493| Rotator cuff repair  is considered medically necessary for a partial thickness tear when ALL of the following criteria
L494| are met:
L495| • Pain ≥ 4 on the VAS scale which int erferes with age -appropriate activities of daily living
L496| • Weakness of rotator cuff muscle(s)
L497| • Physical exam demonstrating a positive response to at least ONE  of the following tests:
L498| o Drop arm test
L499| o Painful arc test
L500| o Full/empty can test
L501| o Weakness of external rot ation
L502| • Recent advanced imaging confirm s a partial thickness tear
L503| • Symptoms present for at least 3 months
L504| • Failure of at least 6 weeks of conservative management
L505| Revision Rotator Cuff Repair
L506| Tobacco cessation  requirement . Adherence to a tobacco cessation program resulting in abstinence from
L507| tobacco for at least 6 weeks prior to revision surgery is required.
L508| Revision rotator cuff repair
L509| Revision rotator cuff repair  is considered medically necessary when ALL of the following c riteria are met:
L510| • Documentation of nicotine -free status for at least 6 weeks prior to surgery
L511| • Shoulder pain ≥ 4 on the VAS scale exacerbated by movement
L512| • Weakness of rotator cuff muscle(s) (less than grade 4/5 on manual muscle testing)
L513| • Recent advanced imaging confirm s a full thickness tear
L514| • Failure of at least 12 weeks of conservative management
L515| Contraindications  rotator cuff repair
L516| Rotator cuff repair  is contraindicated when ANY  of the following are present:
L517| • Active infection of the joint
L518| • Active systemic bacteremia
L519| • Active skin infection (exception recurrent cutaneous staph infections) or open wound within the planned
L520| surgical site of the shoulder
L521| • Rapidly progressive neurological disease
L522| Joint Surgery
L523| © 2023 Carelon Medical Benefits Management. All rights reserved .  16 Revision rotator cuff repair is contraindicated when  ANY of the following  are present :
L524| • Recent history of a revision surgery
L525| • Rotator cuff arthropathy defined as a combination of arthritis and lack of rotator cuff
L526| • Active infection of the joint
L527| • Active systemic bacteremia
L528| • Active skin infe ction (exception recurrent cutaneous staph infections) or open wound within the planned
L529| surgical site of the shoulder
L530| • Rapidly progressive neurological disease
L531| • Wheelchair bound and/or assistive device dependent
L532| Exclusions  rotator cuff repair
L533| For treatment  of all rotator cuff tears, i ndications other than those addressed in this guideline are considered not
L534| medically necessary  including, but not limited to, the following:
L535| • Treatment of asymptomatic, full thickness rotator cuff tear
L536| • Deltoid or rotator cuff paralysis
L537| • Use of xenografts or biologic scaffold for augmentation or bridging reconstruction
L538| • Use of platelet rich plasma or other biologics
L539| • Concomitant subacromial decompression/acromioplasty
L540| Labrum Repair
L541| Labral tear including superior labral anter ior-posterior (SLAP) tears
L542| Labrum repair  is considered medically necessary when ALL of the following criteria are met:
L543| • Shoulder pain ≥ 4 on the VAS scale which interferes with age -appropriate activities of daily living
L544| • Symptoms aggravated by heavy lifting,  pushing, and overhead motion
L545| • Physical exam demonstrating a positive response to at least ONE  of the following tests:
L546| o O’Brien (active compression) test
L547| o Anterior slide test
L548| o Biceps load test (I and II)
L549| o Pain provocation test
L550| o Crank test
L551| o Jobe relocation test
L552| o Forced shoulder abduction and elbow flexion test
L553| o Resisted supination external rotation test
L554| • MRI demonstrating a labral tear that is not a Bankart lesion and is consistent with subjective and objective
L555| findings
L556| • Failure of at least 12 weeks of conservative ma nagement
L557| Joint Surgery
L558| © 2023 Carelon Medical Benefits Management. All rights reserved .  17 Other Arthroscopic and Open Procedures
L559| Acromioclavicular arthritis
L560| Partial claviculectomy  (includes Mumford procedure) is considered medically necessary when ALL of the
L561| following criteria are met:
L562| • Pain at the acromioclavicular (AC) joint aggravate d by shoulder motion
L563| • Positive cross -arm adduction test
L564| • Tenderness over the acromioclavicular joint
L565| • Imaging findings (x -ray or MRI) consistent with acromioclavicular joint arthritis  (ONE  of the following)
L566| o Moderate to severe degenerative joint disease of the acromioclavicular joint, distal clavicle
L567| edema, or osteolysis of the distal clavicle on MRI
L568| o Moderate to severe acromioclavicular joint arthritis on x -ray
L569| • Failure of at least 12 weeks of conservative man agement
L570| Adhesive capsulitis
L571| Arthroscopically assisted lysis of adhesions/capsular release is considered medically necessary for post -
L572| traumatic, post -surgical, or idiopathic stiffness of the shoulder when ALL of the following criteria are met :
L573| • Shoulder pai n ≥ 4 on the VAS scale which interferes with age -appropriate activities of daily living
L574| • Reduced passive range of motion of the affected glenohumeral joint by at least 50% compared to
L575| unaffected shoulder
L576| • Failure of at least 12 weeks of conservative manageme nt
L577| Manipulation under anesthesia (MUA)  is considered medically necessary for post -traumatic, post -
L578| surgical, or idiopathic stiffness of the shoulder when ALL of the following criteria are met :
L579| • Shoulder pain ≥ 4 on the VAS scale which interferes with age -appropriate activities of daily living
L580| • Reduced passive range of motion of the affected glenohumeral joint by at least 50% compared to
L581| unaffected shoulder
L582| • Failure of at least 12 weeks of conservative management
L583| Chronic shoulder instability or laxity
L584| Capsulorrh aphy (Bankart procedure)  is considered medically necessary when ALL of the following criteria are
L585| met:
L586| • History of a shoulder dislocation or recurrent subluxation
L587| • Positive apprehension/relocation test
L588| • Shoulder pain and/or instability which interferes with  age-appropriate activities of daily living
L589| • MRI demonstrates at least ONE  of the following:
L590| o Bankart/labral lesion consistent with the clinical instability
L591| o Hill-Sachs lesion
L592| o Capsular tear
L593| o Capsular redundancy with clinical multidirectional instability
L594| • Failure of at least 12 weeks of conservative management (unless history of traumatic dislocation and
L595| multiple dislocations during management)*
L596| Joint Surgery
L597| © 2023 Carelon Medical Benefits Management. All rights reserved .  18 *For traumatic instability, e arly surgery may be considered for patients with large bone defects or p atients
L598| under age 35.
L599| Subacromial impingement syndrome
L600| Subacromial decompression/acromioplasty  may be considered medically necessary  for ANY  of the following
L601| indications :
L602| • Symptomatic os acromiale
L603| • Malunited fractures of the acromion/proximal humerus resulting in symptomatic  mechanical impingement
L604| • Local benign/malignant tumor resulting in symptomatic mechanical  impingement
L605| Subacromial decompression/acromioplasty is otherwise considered not medically necessary  for all other
L606| indications.
L607| Synovectomy
L608| Synovectomy  refers to removal of the synovial lining of the joint when it has become symptomatic due to
L609| inflammation, irritation, or pathology. Synovectomy may be performed in a single joint compartment (limited) or
L610| multiple compartme nts (extensive).
L611| Partial or complete synovectomy  is considered medically necessary when BOTH  of the following criteria are
L612| met:
L613| • Symptomatic (pain, swelling, limited function) synovitis caused by ANY  of the following:
L614| o Synovial plica (partial synovectomy)
L615| o Inflammatory arthritides (e.g., rheumatoid arthritis, psoriatic arthritis)
L616| o Crystalline arthropathy (e.g., gout, pseudogout)
L617| o Felty’s syndrome
L618| o Pigmented villonodular synovitis (PVNS)
L619| o Synovial hemangioma
L620| o Synovial chondromatosis/osteochondromatosis
L621| o Hemophilic  synovitis or arthropathy
L622| o Infection (bacterial or fungal septic arthritis)
L623| • Failure of at least (6) 12 weeks of conservative management
L624| Exclusion
L625| Synovectomy performed solely for visualization or approach, traumatic reactive synovitis.
L626| Debridement
L627| Debridement of discrete structures of the shoulder (e.g., humeral bone, humeral articular cartilage, glenoid
L628| bone, glenoid articular cartilage, biceps tendon, biceps anchor complex, labrum, articular capsule, articular side of
L629| the rotator cuff , bursal side of the rotator cuff, subacromial bursa, foreign body[ies]) is considered medically
L630| necessary when ALL of the following criteria are met:
L631| • Shoulder pain unresponsive to 12 weeks of conservative management
L632| • Surgical pathology is confirmed by imag ing
L633| • Limited debridement involves 1 or 2 discrete structures
L634| • Extensive debridement involves 3 or more discrete structures
L635| Joint Surgery
L636| © 2023 Carelon Medical Benefits Management. All rights reserved .  19 Tendinopathy of the long head of the biceps
L637| Biceps tenodesis or tenotomy  is considered medically necessary for shoulder pain when EITH ER of the
L638| following criteria are met:
L639| • Criteria for SLAP tear
L640| • ALL of the following:
L641| o Pain in the front of the shoulder and/or clicking, popping , or catching sensation when using the
L642| arm and shoulder
L643| o Clinical exam is consistent with long head of biceps pathology (at least two of the following:
L644| anterior shoulder pain, weakness, tenderness over the biceps groove, pain in the anterior
L645| shoulder during resisted supination of the forearm [Yergason test], positive Speed test)
L646| o MRI findings consistent with biceps tendinopathy
L647| o Failure of at least 12 weeks of supervised conservative management (requirement is waived if
L648| criteria for rotator cuff tear are met )
L649| Exclusions
L650| Indications other than those addressed in this guideline are considered not medically necessary  including, but
L651| not limited to, the following:
L652| • Subacromial (balloon) spacer
L653| Selected References
L654| 1. Davies A, Singh P, Reilly P, Sabharwal S, Malhas A. Superior capsule reconstruction, partial cuff repair, graft interposition ,
L655| arthroscopic debridement or balloon spacers for large and massive irreparable rotator cuff tears: a systematic review and met a-
L656| analysis. J Orthop Surg Res. 2022;17(1):552.
L657| 2. Gebremariam L, Hay EM, Koes BW, Huisstede BM. Effectiveness of surgical and postsurgical interventions for the subacromial
L658| impingement syndrome: a systematic review. Arch Phys Med Rehabil. 2011;92(11):1900 -13.
L659| 3. Hughes JD, Davis B, Whicker E, Sprowls GR, Barrera L, Baradaran A, Sabzevari S, Burnham JM, Shah AA, Lin A.
L660| Nonarthroplasty options for massive, irreparable rotator cuff tears have improvement in range of motion and patient -reported
L661| outcomes at short -term fol low-up: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2022;16:16.
L662| 4. Huisstede BM, Koes BW, Gebremariam L, Keijsers E, Verhaar JA. Current evidence for effectiveness of interventions to treat
L663| rotator cuff tears. Man Ther. 2011;16(3):217 -30.
L664| 5. Itoi E . Rotator cuff tear: physical examination and conservative treatment. J Orthop Sci. 2013;18(2):197 -204.
L665| 6. Karjalainen TV, Jain NB, Page CM, Lähdeoja TA, Johnston RV, Salamh P, Kavaja L, Ardern CL, Agarwal A, Vandvik PO,
L666| Buchbinder R. Subacromial decompressio n surgery for rotator cuff disease. Cochrane Database Syst Rev. 2019;1(1):Cd005619.
L667| 7. Khazzam M, Gee AO, Pearl M. Management of Glenohumeral Joint Osteoarthritis. J Am Acad Orthop Surg. 2020;28(19):781 -9.
L668| 8. Lähdeoja T, Karjalainen T, Jokihaara J, Salamh P, Kav aja L, Agarwal A, Winters M, Buchbinder R, Guyatt G, Vandvik PO,
L669| Ardern CL. Subacromial decompression surgery for adults with shoulder pain: a systematic review with meta -analysis. Br J
L670| Sports Med. 2020;54(11):665 -73.
L671| 9. Li Y, Zhao L, Zhu L, Li J, Chen A. Int ernal fixation versus nonoperative treatment for displaced 3 -part or 4 -part proximal humeral
L672| fractures in elderly patients: a meta -analysis of randomized controlled trials. PloS one. 2013;8(9):e75464.
L673| 10. Mao F, Zhang DH, Peng XC, Liao Y. Comparison of Surgica l versus Non -Surgical Treatment of Displaced 3 - and 4 -Part
L674| Fractures of the Proximal Humerus: A Meta -Analysis. J Invest Surg. 2015;28(4):215 -24.
L675| 11. Saltychev M, Virolainen P, Laimi K. Conservative treatment or surgery for shoulder impingement: updated meta -analysis.
L676| Disability and rehabilitation. 2020;42(11):1634 -5.
L677| 12. Song L, Miao L, Zhang P, Wang WL. Does concomitant acromioplasty facilitate arthroscopic repair of full -thickness rotator cuff
L678| tears? A meta -analysis with trial sequential analysis of randomized co ntrolled trials. SpringerPlus. 2016;5(1):685.
L679| 13. Sun Z, Fu W, Tang X, Chen G, Li J. Systematic review and Meta -analysis on acromioplasty in arthroscopic repair of full -thickness
L680| rotator cuff tears. Acta Orthop Belg. 2018;84(1):54 -61.
L681| Joint Surgery
L682| © 2023 Carelon Medical Benefits Management. All rights reserved .  20 14. Vandvik PO, Lähdeoja T, A rdern C, Buchbinder R, Moro J, Brox JI, Burgers J, Hao Q, Karjalainen T, van den Bekerom M,
L683| Noorduyn J, Lytvyn L, Siemieniuk RAC, Albin A, Shunjie SC, Fisch F, Proulx L, Guyatt G, Agoritsas T, Poolman RW.
L684| Subacromial decompression surgery for adults with s houlder pain: a clinical practice guideline. BMJ. 2019;364:l294.
L685| 15. Weber S, Chahal J. Management of Rotator Cuff Injuries. J Am Acad Orthop Surg. 2020;28(5):e193 -e201.
L686| Codes
L687| The following code list is not meant to be all -inclusive. Authorization requirements  will vary by health plan. Please consult the
L688| applicable health plan for guidance on specific procedure codes.
L689| Specific CPT codes for services should be used when available. Nonspecific or not otherwise classified codes may be subject
L690| to additional documen tation requirements and review.
L691| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L692| identify the service or procedure to be performed.  If no such code exists, contact the health plan directl y and report the
L693| service or procedure using the appropriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in
L694| 99). Do not submit a code that is “close to” the procedure performed in lieu of an unlisted code. Correct coding dema nds that
L695| the code reported is appropriate for the service provided (i.e., a code that most accurately represents the service provided) ,
L696| and not a code that is similar but represents another service.  (CPT® Assistant,  December 2010)
L697| CPT/HCPCS
L698| CPT® (Current  Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five-digit codes,
L699| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L700| practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein.
L701| 23000  Removal of subdeltoid calcareous deposit
L702| 23020  Capsular contracture release (eg, Sever type procedure)
L703| 23105  Arthrotomy; glenohumeral joint, with synovectomy, with or without biopsy
L704| 23107  Arthrotomy, glenohumeral joint, with joint exploration, with or without removal of loose or foreign body
L705| 23120  Claviculectomy; partial
L706| 23130  Acromioplasty or acromionectomy, partial, with or without coracoacromial ligament release
L707| 23410  Repair of ruptured musculotendinous cuff (eg, rotator cuff) open; acute
L708| 23412  Repair of ruptured musculotendinous cuff (eg, rotator cuff) open; chronic
L709| 23415  Coracoacromial ligament release, with or without acromioplasty
L710| 23420  Reconstruction of complete shoulder (rotator) cuff avulsion, chronic (includes acromioplasty)
L711| 23430  Tenodesis of long tendon of biceps
L712| 23440  Resection or transplantation of long tendon of biceps
L713| 23450  Capsul orrhaphy, anterior; Putti -Platt procedure or Magnuson -type operation
L714| 23455  Capsulorrhaphy, anterior; with labral repair (eg, Bankart procedure)
L715| 23460  Capsulorrhaphy, anterior, any type; with bone block
L716| 23462  Capsulorrhaphy, anterior, any type; with coracoid process transfer
L717| 23465  Capsulorrhaphy, glenohumeral joint, posterior, with or without bone block
L718| 23466  Capsulorrhaphy, glenohumeral joint, any type multidirectional instability
L719| 23700  Manipulation under anesthesia, shoulder joint, including appl ication of fixation apparatus (dislocation excluded)
L720| 29805  Arthroscopy, shoulder, diagnostic, with or without synovial biopsy (separate procedure)
L721| 29806  Arthroscopy, shoulder, surgical; capsulorrhaphy
L722| 29807  Arthroscopy, shoulder, surgical; repair of SLAP lesion
L723| 29819  Arthroscopy, shoulder, surgical; with removal of loose body or foreign body
L724| 29820  Arthroscopy, shoulder, surgical; synovectomy, partial
L725| 29821  Arthroscopy, shoulder, surgical; synovectomy, complete
L726| 29822  Arthroscopy, shoulder, surgical ; debridement, limited, 1 or 2 discrete structures (eg, humeral bone, humeral
L727| articular cartilage, glenoid bone, glenoid articular cartilage, biceps tendon, biceps anchor complex, labrum,
L728| Joint Surgery
L729| © 2023 Carelon Medical Benefits Management. All rights reserved .  21 articular capsule, articular side of the rotator cuff, bursal side o f the rotator cuff, subacromial bursa, foreign
L730| body[ies])
L731| 29823  Arthroscopy, shoulder, surgical; debridement, extensive, 3 or more discrete structures (eg, humeral bone, humeral
L732| articular cartilage, glenoid bone, glenoid articular cartilage, biceps tendon , biceps anchor complex, labrum,
L733| articular capsule, articular side of the rotator cuff, bursal side of the rotator cuff, subacromial bursa, foreign
L734| body[ies])
L735| 29824  Arthroscopy, shoulder, surgical; distal claviculectomy including distal articular surface
L736| 29825  Arthroscopy, shoulder, surgical; with lysis and resection of adhesions, with or without manipulation
L737| 29826  Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with
L738| coracoacromial ligament (i.e., a rch) release, when performed (list separately in addition to code for primary
L739| procedure)
L740| 29827  Arthroscopy, shoulder, surgical; with rotator cuff repair
L741| 29828  Arthroscopy, shoulder, surgical; biceps tenodesis
L742| Joint Surgery
L743| © 2023 Carelon Medical Benefits Management. All rights reserved .  22 Hip Arthroplasty (Total/Partial/Revision Hip
L744| Replacement , Acetabuloplasty, Resection Arthroplasty )
L745| Description and Scope
L746| Total hip arthroplasty (THA), also referred to as total hip replacement (THR), involves removal of the femoral head
L747| and acetabulum and placement of a prosthesis anchored to the bone. Numerous implants composed of various
L748| biomaterials have been approved by the U.S. Food and Drug Administration (FDA) for use in hip arthroplasty. The
L749| goal of the procedure is long -term pain relief and restoration of function. All arthroplasty and
L750| acetabuloplasty/resection arthroplasty procedures are inclusive of synovectomy, re moval of osteophytes, removal
L751| of loose bodies, manipulation of the hip, and release or repair of structures to gain entrance to the hip joint.
L752| Degenerative joint disease, or osteoarthritis, is the most common condition leading to the need for total hip
L753| arthroplasty. Other conditions that may also cause significant hip joint damage include neoplasm, femoral
L754| fracture, avascular necrosis (osteonecrosis), inflammatory arthritis (e.g., rheumatoid arthritis) and developmental
L755| hip dysplasia.
L756| This guideline addre sses hip arthroplasty when performed as an elective, non -emergent  procedure and not as
L757| part of the care of an acute fracture (excluding fracture of implant and periprosthetic fracture).
L758| Clinical Indications
L759| The following general requirements apply to all i ndications except where they differ from the specific
L760| requirements. The specific requirements take precedence over any stated general requirement.
L761| General Information
L762| The terms in the section provide operational definitions when they are referenced as req uirements in the
L763| guideline.
L764| Documentation supporting medical necessity  and a clearly stated plan of care  should be submitted at the time of
L765| the request and must include the following components:
L766| Clinical notes  describing symptom duration and severity, spe cific functional limitations related to symptoms, and
L767| type and duration of all therapeutic measures provided. If conservative management is not appropriate, the
L768| reason must be clearly documented.
L769| Conservative management1 must include a combination of strat egies to reduce inflammation, alleviate pain, and
L770| correct underlying dysfunction, including physical therapy AND  at least ONE  complementary conservative
L771| treatment strategy.
L772| • Physical therapy requirement  includes ANY  of the following:
L773| o Physical therapy rende red by a qualified provider of physical therapy services
L774| o Supervised home treatment program that includes ALL of the following:
L775| ▪ Participation in a patient -specific or tailored program
L776| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ab ility to
L777| perform exercises
L778| ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L779| o Exception to the physical therapy requirement in unusual circumstances (for instance,
L780| intractable pain so severe that physical therapy is not possible) w hen clearly documented in the
L781| medical record
L782| Joint Surgery
L783| © 2023 Carelon Medical Benefits Management. All rights reserved .  23 • Complementary conservative treatment requirement  includes ANY  of the following:
L784| o Anti-inflammatory medications and analgesics2
L785| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L786| o Intra-articular corticosteroid injection(s)2
L787| o Alternative therapies such as activity modification, and/or a trial period of rest (e.g., from the
L788| aggravating/contributing factors), where applicable
L789| 1 Additional condition or procedure -specific requirements may a pply and can be found in the respective sections
L790| of the guideline.
L791| 2 In the absence of contraindications
L792| Clinical reevaluation . In most cases, reevaluation should include a physical examination. Direct contact by other
L793| methods, such as telephone communication or electronic messaging, may substitute for in -person evaluation
L794| when circumstances preclude an office visit. Clinical ree valuation must be done in reasonable proximity to the
L795| anticipated date of service such that the patient’s condition would be unlikely to change by the date of service.
L796| Failure of conservative management  requires ALL of the following:
L797| • Patient has completed a full course of conservative management (as defined above) for the current
L798| episode of care
L799| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L800| • More invasive forms of therapy are being considered
L801| Documentation of  compliance with a plan of therapy that includes elements from these areas is required where
L802| conservative management is appropriate.
L803| Reporting symptom severity . Severity of pain and its associated impact on activities of daily living (ADLs) and
L804| instrumenta l ADLs (IADLs) are key factors in determining the need for intervention. For purposes of this guideline,
L805| significant pain and functional impairment refer to pain rated at least 3 out of 10 in intensity and associated with
L806| inability to perform at least two (2) ADLs and/or IADLs.
L807| Imaging reports  obtained within the past 12 months describing the degree of cartilage damage as determined by
L808| either or both of the following methods:
L809| • X-ray report or provider interpretation of x -rays that utilizes or can be correlated with the Kellgren -
L810| Lawrence grading system of osteoarthritis
L811| • MRI report from a radiologist that utilizes or can be correlated with the modified Outerbridge or similar
L812| classification system related to articular cartilage injury and osteoarthritis
L813| See Appendix  for a description of these grading systems.
L814| For x -ray interpretation, the provider shall submit a detailed imaging description that correlates with clinical
L815| findings of the request ed procedure. In the absence of a detailed description , the provider may to submit a report
L816| from an independent radiologist. The results of all imaging studies should correlate with the clinical findings in
L817| support of the requested procedure.
L818| For advanced  imaging (CT, MRI, ultrasound, bone scan), there must be a report from a radiologist that correlates
L819| with clinical findings. In the absence of such a report, the summary findings from the radiology report should be
L820| included in the clinical records .
L821| Imagin g reports should be thorough and describe the presence or absence of subchondral cysts, subchondral
L822| sclerosis, periarticular osteophytes, joint subluxation, avascular necrosis , or bone on bone articulations. The
L823| degree of joint space narrowing should also be noted.
L824| General Recommendations
L825| Tobacco cessation . Adherence to a tobacco cessation program resulting in abstinence from tobacco for at least
L826| 6 weeks prior to surgery is strongly recommended.
L827| Joint Surgery
L828| © 2023 Carelon Medical Benefits Management. All rights reserved .  24 Diabetes . It is strongly recommended that a patient with a history of diabetes maintain a hemoglobin A1C of 8%
L829| or less prior to any joint replacement surgery.
L830| Body mass index (BMI) . It is strongly recommended that a patient with a BMI equal to or greater than 40 attempt
L831| weight reduction prior to surgery.
L832| Where the re are patient specific modifiable comorbidities that may adversely impact patient reported outcomes or
L833| the health status of the patient a shared decision -making process with the patient to discuss these modifiable
L834| comorbidities is strongly recommended and  should be documented.
L835| Primary Total Hip Arthroplasty
L836| Primary total hip arthroplasty is considered medically necessary for ANY  of the following indications:
L837| • Primary and secondary tumors of the proximal femur
L838| • Hip fracture or complications including malunio n, nonunion or failed prior fixation
L839| • Failed previous hip fracture fixation
L840| • Avascular necrosis (osteonecrosis) with unresponsive severe pain
L841| • Revision of hip arthrodesis
L842| • Joint damage or destruction due to osteoarthritis, inflammatory disease or other chronic condition when
L843| ALL of the following requirements have been met:
L844| o Imaging evidence of significant joint destruction and cartilage loss, defined as Tönnis grade 3,
L845| modifi ed Outerbridge grade III – IV, or Kellgren -Lawrence grade 3 – 4
L846| o Limited range of motion, antalgic gait and disabling pain of at least 3 months’ duration
L847| o Pain with passive motion of the hip
L848| o Failure of at least 3 months of non -surgical conservative management (unless radiographs show
L849| Kellgren -Lawence grade 4)
L850| o Functional limitation secondary to hip pathology which interferes with the ability to perform age-
L851| appropriate daily activities
L852| Primary  Partial Hip Arthroplasty
L853| Partial hip arthroplasty (unipolar, bipolar, hemi -) is considered medically necessary for ANY of the following
L854| indications:
L855| Femoral neck fracture not amenable to internal fixation or total hip arthroplasty , or
L856| previous fixation  failed
L857| Partial hip resurfacing
L858| Partial hip resurfacing of the femoral head is considered medically necessary when ALL of the following criteria
L859| are met :
L860| • Osteonecrosis of the femoral head (less than 50% involvement) with subchondral collapse
L861| • Imaging evidence of significant joint destruction and cartilage loss, defined as Tönnis grade 3, modified
L862| Outerbridge grade III – IV, or Kellgren -Lawrence grade 3 – 4
L863| • Limited range of motion, antalgic gait and disabling pain of at least 3 months’ duration
L864| • Pain with passiv e internal or external rotation
L865| • Failure of at least 3 months of non -surgical conservative management (unless radiographs show
L866| Kellgren -Lawence grade 4)
L867| Joint Surgery
L868| © 2023 Carelon Medical Benefits Management. All rights reserved .  25 • Functional limitation secondary to hip pathology which interferes with the ability to perform  age-
L869| appro priate daily activities
L870| Total hip resurfacing
L871| Total hip resurfacing arthroplasty (HRA) is considered medically necessary when ALL of the following criteria are
L872| met:
L873| • Active, fit individual
L874| • Normal proximal femoral bone geometry and bone quality
L875| • Otherwise eligible for a conventional primary total hip replacement (THR):
L876| o Imaging evidence of significant joint destruction and cartilage loss, defined as Tönnis grade 3,
L877| modified Outerbridge grade III – IV, or Kellgren -Lawrence grade 3 – 4
L878| o Limited range of motion, antalgic gait and disabling pain of at least 3 months’ duration
L879| o Pain with passive internal or external rotation
L880| o Failure of at least 3 months of non -surgical conservative management (unless radiographs show
L881| Kellgren -Lawence grade 4)
L882| o Functional limitation secondary to hip pathology which interferes with the ability to perform  age-
L883| appropriate daily activities
L884| • Likely to outlive a current conventional total hip replacement
L885| Contraindications for partial/ total hip resurfacing
L886| • Advanced age
L887| • Severe osteoporosis
L888| • Renal insufficiency
L889| • Known metal hypersensitivity
L890| • Inadequate bone stock to support the femoral implant
L891| • Femoral neck or head cysts
L892| • Severe hip dysplasia
L893| • Small or bone -deficient acetabulum
L894| Revision Total Hip Arthroplasty
L895| Revision total hip arthroplasty is considered medically necessary when at least ONE  of the following conditions is
L896| present:
L897| • Aseptic loosening
L898| • Substantial osteolysis of the weight bearing surface s with or without periarticular osteolysis
L899| • Progressive soft tissue or bone reaction including symptomatic synovitis
L900| • Component instability, failure,  or recall
L901| • Displaced periprosthetic fracture or irreducible dislocation
L902| • Hip reconstruction after p revious removal of prosthesis due to infection or catastrophic failure
L903| • Metal on metal implant:
L904| o An elevated synovial cobalt level
L905| Joint Surgery
L906| © 2023 Carelon Medical Benefits Management. All rights reserved .  26 o An increased cobalt/chromium level
L907| • Recurrent disabling pain or significant functional disability that persists despite at least 3 months of
L908| conservative management in conjunction with ANY  of the following:
L909| o Antalgic or Trendelenburg gait
L910| o Abnormal findings confirmed by p lain radiography or imaging studies such as implant malposition
L911| or impingement
L912| o Leg length inequality
L913| o Audible noise
L914| Acetabuloplasty  (Whitman, Colonna, Haygrove s, or cup type *)
L915| Acetabuloplasty is considered medically necessary when ONE  of the following is present:
L916| • Acetabular arthritis where there is planned removal of articular cartilage and replacement with
L917| interposition tissue
L918| • Hip instability due to a structurally deficient acetabulum where acetabular augmentation is planned
L919| *See Code section  for applicable CPT code 27120.
L920| Resection Arthroplasty of the Hip
L921| Resection arthroplasty of the hip, femoral head ostectomy, or Girdlestone resection arthroplasty is considered
L922| medically necessary when at lea st ONE  of the following conditions is present:
L923| • Painful stiff hip after infection (tuberculosis of the hip or otherwise)
L924| • Peri-prosthetic infection
L925| • Aseptic loosening of the hip
L926| • Recurrent dislocation of the hip
L927| • Failed internal fixation of a femoral neck fract ure
L928| • Unsalvageable failed hip replacement
L929| Contraindications
L930| Total /Partial hip arthroplasty
L931| • Presence of a skin infection at the surgical site
L932| • Presence of a systemic infection
L933| • Rapidly progressive neurological disease
L934| • Neuropathic joint
L935| • Intra-articular corticosteroid injection within the past 6 weeks in the joint being replaced
L936| Exclusions
L937| Indications for total hip arthroplasty , partial hip arthroplasty, total hip resurfacing , or partial hip resurfacing  other
L938| than those addressed in this g uideline are considered not medically necessary .
L939| Joint Surgery
L940| © 2023 Carelon Medical Benefits Management. All rights reserved .  27 Selected References
L941| 1. American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the hip - evidence -based clinical practice
L942| guideline Rosemont IL: American Academy of Orthopedic Surgeons; 2017. Available from:
L943| https://www.aaos.org/globalassets/quality -and-practice -resources/osteoarthritis -of-the-hip/oa -hip-cpg_6 -11-19.pdf.
L944| 2. Arbab D, König DP. Atraumatic Femoral Head Necrosis in Adults. Dtsch Arztebl Int. 2016;113(3):31 -8.
L945| 3. Department of Veterans Af fairs Department of Defense. VA/DoD Clinical Practice Guideline for the non -surgical management of
L946| hip & knee osteoarthritis, 2020, Version 2.0. Retrieved from
L947| https://www.healthquality.va.gov/guidelines/CD/OA/VADoDOACPG.pdf on May 17, 2023.
L948| 4. Hagel A, Siekm ann H, Delank KS. Periprosthetic femoral fracture - an interdisciplinary challenge. Dtsch Arztebl Int.
L949| 2014;111(39):658 -64.
L950| 5. National Institute for Health and Care Excellence. Hip fracture: management. London: National Institute for Health and Care
L951| Excellen ce (NICE); 2023 Jan 6. (NICE Clinical Guidelines, No. 124.) Available from: nice.org.uk.
L952| 6. Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the
L953| management of osteoarthritis: The chronic osteoar thritis management initiative of the U.S. bone and joint initiative. Semin
L954| Arthritis Rheum. 2014;43(6):701 -12.
L955| Codes
L956| The following code list is not meant to be all -inclusive. Authorization requirements will vary by health plan. Please consult the
L957| applicabl e health plan for guidance on specific procedure codes.
L958| Specific CPT codes for services should be used when available. Nonspecific or not otherwise classified codes may be subject
L959| to additional documentation requirements and review.
L960| Medical necessity revie ws are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L961| identify the service or procedure to be performed.  If no such code exists, contact the health plan directly and report the
L962| service or procedure using the appropr iate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in
L963| 99). Do not submit a code that is “close to” the procedure performed in lieu of an unlisted code. Correct coding demands that
L964| the code reported is appropriate for the servi ce provided (i.e., a code that most accurately represents the service provided),
L965| and not a code that is similar but represents another service. (CPT® Assistant,  December 2010)
L966| CPT/HCPCS
L967| CPT® (Current Procedural Terminology) is a registered trademark of the  American Medical Association (AMA). CPT® five-digit codes,
L968| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L969| practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein.
L970| 27120  Acetabuloplasty; (eg, Whitman, Colonna, Haygroves, or cup type)
L971| 27122  Acetabuloplasty; resection, femoral head (eg, Girdlestone procedure)
L972| 27125  Hemiarthroplasty, hip, partial (eg, femoral stem prosthesis, bipolar arthroplasty)
L973| 27130  Arthroplasty, acetabular and proximal femoral prosthetic replacement (total hip arthroplasty), with or without
L974| autograft or allograft
L975| 27132  Conversion of previous hip surgery to total hip arthroplasty, with or without autograft or allograft
L976| 27134  Revision of total hip arthroplasty; both components, with or without autograft or allograft
L977| 27137  Revision of total hip arthroplasty; acetabular component only, with or without autograft or allog raft
L978| 27138  Revision of total hip arthroplasty; femoral component only, with or without allograft
L979| S2118  Metal -on-metal total hip resurfacing, including acetabular and femoral components
L980| Joint Surgery
L981| © 2023 Carelon Medical Benefits Management. All rights reserved .  28 Hip Arthroscopy
L982| Description and Scope
L983| Hip arthroscopy is most often utilized in diagnosing and treating conditions of the joint space which impede
L984| normal function and result in pain and disability. A more recent application of this procedure is treatment of
L985| femoroacetabular impingement syndrom e (FAIS), a condition of the hip in which the acetabular rim of the pelvis
L986| articulates abnormally with the femoral head. Over time, contact may result in damage to joint cartilage,
L987| potentially leading to degenerative joint disease. Hip arthroscopy has also  been applied to the treatment of
L988| symptomatic labral tears not associated with advanced arthritis of the hip joint.
L989| Surgical treatment of FAIS and/or labral tears may involve an open approach, arthroscopic surgery, or a
L990| combination of the two. The surgic al treatment of FAIS and labral tears is inclusive of the management of any
L991| chondral or soft tissue debridement that is done. It is also inclusive of diagnostic hip arthroscopy. Components of
L992| FAIS surgery include the following: labral repair , acetabuloplas ty, and f emoroplasty .
L993| This guideline addresses hip arthroscopy when performed as an elective, non -emergent  procedure and not as
L994| part of the care of an acute fracture.  It does not cover labral reconstructions, capsular plications, or endoscopic
L995| procedures d one outside of the hip capsule.
L996| Clinical Indications
L997| General Information
L998| The terms in the section provide operational definitions when they are referenced as requirements in the
L999| guideline.
L1000| Documentation supporting medical necessity and a clearly stated plan of care should be submitted at the time of
L1001| the request and must include the following components:
L1002| Imaging report . The provider shall submit a detailed imaging report for studies obtaine d within the past 12
L1003| months that correlates with clinical findings of the requested procedure. In the absence of a detailed report, the
L1004| provider will be required to submit a report from an independent radiologist. The results of all imaging studies
L1005| should correlate with the clinical findings in support of the requested procedure.
L1006| For x -ray interpretation, the provider shall submit a detailed imaging description that correlates with clinical
L1007| findings of the requested procedure. In the absence of a detailed description, the provider may submit a
L1008| radiologist’s report.
L1009| For advanced imaging (CT, MRI, ultrasound, bone scan), there must be a report from a radiologist that correlates
L1010| with clinical findings. In the absence of such a report, the summary findings fro m the radiology report should be
L1011| included in the clinical records .
L1012| Conservative management . In the majority of cases, a period of conservative management is appropriate prior
L1013| to intervention. Conservative management1 must include a combination of strategie s to reduce inflammation,
L1014| alleviate pain, and correct underlying dysfunction, including physical therapy AND  at least ONE  complementary
L1015| conservative treatment strategy.
L1016| • Physical therapy requirement  includes ANY  of the following:
L1017| o Physical therapy rendered by a qualified provider of physical therapy services
L1018| o Supervised home treatment program that includes ALL of the following:
L1019| ▪ Participation in a patient -specific or tailored program
L1020| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ability to
L1021| perform exercises
L1022| Joint Surgery
L1023| © 2023 Carelon Medical Benefits Management. All rights reserved .  29 ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L1024| o Exception to the physical therapy requirement in unusual circumstances (for inst ance,
L1025| intractable pain so severe that physical therapy is not possible) when clearly documented in the
L1026| medical record
L1027| • Complementary conservative treatment requirement  includes ANY  of the following:
L1028| o Anti-inflammatory medications and analgesics2
L1029| o Adjunctive  medications such as nerve membrane stabilizers or muscle relaxants2
L1030| o Intra-articular corticosteroid injection(s)2
L1031| o Alternative therapies such as activity modification, and/or a trial period of rest (e.g., from the
L1032| aggravating/contributing factors), where ap plicable
L1033| 1 Additional condition or procedure -specific requirements may apply and can be found in the respective sections
L1034| of the guideline.
L1035| 2 In the absence of contraindications
L1036| Clinical reevaluation . In most cases, reevaluation should include a physical ex amination. Direct contact by other
L1037| methods, such as telephone communication or electronic messaging, may substitute for in -person evaluation
L1038| when circumstances preclude an office visit. Clinical reevaluation must be done in reasonable proximity to the
L1039| anticipated date of service such that the patient’s condition would be unlikely to change by the date of service.
L1040| Failure of conservative management  requires ALL of the following:
L1041| • Patient has completed a full course of conservative management (as defined above ) for the current
L1042| episode of care
L1043| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L1044| • More invasive forms of therapy are being considered
L1045| Documentation of compliance with a plan of therapy that includes elements from these areas is required where
L1046| conservative management is appropriate.
L1047| Reporting symptom severity . Severity of pain and its associated impact on activities of daily living (ADLs ) and
L1048| instrumental ADLs (IADLs) are key factors in determining the need for intervention. For purposes of this guideline,
L1049| significant pain and functional impairment refer to pain rated at least 3 out of 10 in intensity and associated with
L1050| inability to perf orm at least two (2) ADLs and/or IADLs.
L1051| Table 1. Quantification of Hip Radiographic Measurements
L1052| Measurement, range  Description
L1053| Arthritis   Lateral center edge angle of Wiberg (CEA)
L1054| < 2 mm joint space  Indicative of arthritis best
L1055| managed non -arthroscopically  22°- 42° Normal
L1056| Alpha angle   < 20°  Dysplastic
L1057| < 55°  Normal  ≥ 20° and ≤ 25°  Borderline dysplastic
L1058| > 55°  Cam femoroacetabular
L1059| impingement  ≥ 40°  Overcovered
L1060| Sharp (acetabular) angle   Tönnis angle
L1061| 33° - 38° Normal  −10° to 10°  Normal
L1062| < 32°  Insignificant  >10°  Acetabular dysplasia
L1063| 39° - 42° Borderline  < -10° Pincer lesion
L1064| > 42°  Dysplastic
L1065| Joint Surgery
L1066| © 2023 Carelon Medical Benefits Management. All rights reserved .  30 Mannava S, Geeslin AG, Frangiamore  SJ, et al. Comprehensive Clinical Evaluation of Femoroacetabular Impingement: Part 2,
L1067| Plain Radiography. Arthrosc Tech. 2017;6(5):e2003 -e2009.
L1068| Hip Arthroscopy
L1069| See Table 1  for Quantification of Hip Radiographic Measurements .
L1070| Diagnostic arthroscopy
L1071| Diagnostic arthroscopy of the hip joint is considered medically necessary for synovial biopsy or tissue harvest
L1072| (chondrocyte), or when the involved joint meets ALL of the following crite ria:
L1073| • Presence of ONE  of the following symptoms
L1074| o Significant pain and functional limitation
L1075| o Instability (e.g., giving way, catching, clicking, locking)
L1076| o Limited range of motion
L1077| • Presence of ONE  of the following physical exam findings
L1078| o Limited range of motion
L1079| o Joint swelling
L1080| o Inconclusive specific diagnostic exam maneuvers
L1081| o Local muscle weakness or atrophy
L1082| • Inconclusive x -ray and/or advanced imaging studies
L1083| • Failure of at least 6 weeks of conservative management
L1084| Exclusion s
L1085| • In-office diagnostic arthroscopy (e.g., mi -eye 2®)
L1086| • Non-intraarticular hip procedures
L1087| Synovectomy
L1088| Any combination of these procedures is considered medically necessary when the following criteria are met:
L1089| • Hip pain associated with grinding, catching, locking , or popping, and ALL of the following:
L1090| o Failure of least 3 months of conservative management
L1091| o Exam findings confirm pain with limited range of motion
L1092| o Imaging (x -ray, CT or MRI) which shows synovial proliferation, calcifications, nodularity,
L1093| inflammation, pannus, or loose body
L1094| Exclusion
L1095| Synovectomy performed solely for visualization or approach, or for post traumatic reactive synovitis
L1096| Removal of loose body
L1097| Removal of loose body is considered medically necessary when BOTH  of the following are present:
L1098| • Radiographic evidence of a cute, post -traumatic, intra -articular foreign body or displaced fracture fragment
L1099| larger than the size of an arthroscopy cannula (5 mm or larger )
L1100| • Hip pain associated with grinding, catching, locking , or popping , and exam findings confirm pain with
L1101| limited range of motion
L1102| Joint Surgery
L1103| © 2023 Carelon Medical Benefits Management. All rights reserved .  31 Exclusion
L1104| • Removal of loose body  for Kellgren -Lawrence grade 4  osteoarthritis
L1105| Arthroscopic treatment of femoroacetabular impingement syndrome (FAIS)
L1106| Acetabuloplasty – ALL of the following criteria are required:
L1107| • Moderate to severe hip pain (primarily in the groin) worsened by flexion activities (e.g., squatting or
L1108| prolonged sitting) that interferes with activities of daily living, which is not explained by another diagnosis.
L1109| • Positive impingement sign on clinical examination, defined as pain elicited with 90 degrees of flexion and
L1110| internal rotation and adduction of the femur, or extension and external rotation)
L1111| • Imaging studies (radiographs, MRI or 3D computed tomography) sugges ting a diagnosis of FAIS,
L1112| including cam impingement and/or pincer impingement as evidenced by ONE  or more of the following:
L1113| o Lateral center edge angle of Wiberg (CEA) >/ - 40 degrees
L1114| o Coxa Profunda or protrusion – acetabular fossa medial to ilioischial line
L1115| o Posterior wall sign – cross -over sign
L1116| • Failure of conservative management for a duration of at least 3 months*, including avoidance of hip
L1117| stretching or any activity that elicits or aggravates symptoms
L1118| • Documentation of a likely causal association between the femoroacetabular impingement morpho logy
L1119| and damage to the acetabular margin or the femoral neck
L1120| Femoroplasty when ALL of the following criteria are met:
L1121| • Moderate to severe hip pain (primarily in the groin) worsened by flexion activities (e.g., squatting or
L1122| prolonged sitting) that interferes  with activities of daily living, which is not explained by another diagnosis.
L1123| • Positive impingement sign on clinical examination, defined as pain elicited with 90 degrees of flexion and
L1124| internal rotation and adduction of the femur, or extension and externa l rotation)
L1125| • Imaging studies (radiographs, MRI or 3D computed tomography) suggesting a diagnosis of FAIS,
L1126| including cam impingement and/or pincer impingement as evidenced by ONE  or more of the following:
L1127| o Pistol -grip deformity
L1128| o Femoral head -neck offset with  an alpha angle greater than 55 degrees
L1129| • Failure of conservative management for a duration of at least 3 months*, including avoidance of hip
L1130| stretching or any activity that elicits or aggravates symptoms
L1131| * Less than the full duration of conservative manage ment is permitted in the presence of an alpha angle
L1132| greater than 65 degrees (a measure of asphericity of the femoral head).
L1133| • Documentation of a likely causal association between the femoroacetabular impingement morphology
L1134| and damage, e.g., a pistol -grip def ormity with a tear of the acetabular labrum and articular cartilage
L1135| damage in the anterosuperior quadrant
L1136| Labral tear
L1137| Hip arthroscopy is considered medically necessary for treatment of labral tear when ALL of the following criteria
L1138| are met:
L1139| • Moderate to severe hip pain (primarily in the groin) worsened by flexion activities (e.g., squatting or
L1140| prolonged sitting) that interferes with activities of daily living, which is not explained by another diagnosis
L1141| • Positive impingement sign on clinical ex amination, defined as pain elicited with 90 degrees of flexion and
L1142| internal rotation and adduction of the femur, or extension and external rotation
L1143| • MRI report that defines or suggests a labral tear
L1144| Joint Surgery
L1145| © 2023 Carelon Medical Benefits Management. All rights reserved .  32 • Failure of conservative management for a duration of at le ast 3 months, including avoidance of hip
L1146| stretching or any activity that elicits or aggravates symptoms
L1147| • No evidence of advanced osteoarthritis, defined as Tönnis grade 2 or greater, or joint space of less than 2
L1148| mm
L1149| • No evidence of severe (Outerbridge grade  IV) chondral damage
L1150| Exclusion
L1151| Arthroscopic lavage and debridement for advanced osteoarthritis of the hip joint
L1152| Exclusions
L1153| Indications other than those addressed in this guideline are considered not medically necessary  including, but
L1154| not limited to, the fo llowing:
L1155| For hip debridement/chondroplasty
L1156| • When done solely for treatment of hip osteoarthritis (Kellgren -Lawrence grade 2  or greater, Tönnis  grade
L1157| 2 or greater)
L1158| For treatment of FAIS /Labral repair
L1159| • Use of capsular plication as the sole treatment of FAIS
L1160| • Capsular plication, capsular repair, labral reconstruction, iliotibial band windowing, trochanteric
L1161| bursectomy, abductor muscle repair, and/or iliopsoas tenotomy, when performed at the time of any FAIS
L1162| surgery, would be considered a component of and inciden tal to the FAIS procedure
L1163| • Evidence of advanced osteoarthritis, defined as Tönnis grade ≥ 2, or joint space narrowing ≤ 2 mm along
L1164| the lateral/medial sourcil (roof or weight -bearing area of acetabulum)
L1165| • Evidence of severe (Outerbridge grade IV) chondral damage
L1166| • Positive broken Shenton line
L1167| • Inclination Tönnis angle greater than 13 -15 degrees
L1168| • Labral repair in the presence of untreated severe hip dysplasia
L1169| Selected References
L1170| 1. Bedi A, Kelly BT. Femoroacetabular impingement. J Bone Joint Surg Am . 2013;95(1):82 -92.
L1171| 2. de SA D, Phillips M, Philippon MJ, Letkemann S, Simunovic N, Ayeni OR. Ligamentum teres injuries of the hip: a systematic
L1172| review examining surgical indications, treatment options, and outcomes. Arthroscopy. 2014 Dec;30(12):1634 -41.
L1173| 3. Kroger EW, Griesser MJ, Kolovich GP, Ellis TJ. Efficacy of surgery for internal snapping hip. Int J Sports Med. 2013
L1174| Oct;34(10):851 -5.
L1175| 4. Lustenberger DP, Ng VY, Best TM, et al. Efficacy of treatment of trochanteric bursitis: a systematic review. Clin J Sp ort Med.
L1176| 2011;21(5):447 -53.
L1177| 5. Mannava S, Geeslin AG, Frangiamore SJ, et al. Comprehensive Clinical Evaluation of Femoroacetabular Impingement: Part 2,
L1178| Plain Radiography. Arthrosc Tech. 2017;6(5):e2003 -e2009.
L1179| 6.  Minkara AA, Westermann RW, Rosneck J, Lync h TS . Systematic Review and Meta -analysis of Outcomes After Hip Arthroscopy
L1180| in Femoroacetabular Impingement. Am J Sports Med. 2019;47(2):488 -500.
L1181| 7. Nelson S J, Webb M L, Lukasiewicz A M, Varthi A G, Samuel A M, Grauer J N.  Is outpatient total hip arthropl asty safe?  J
L1182| Arthroplasty  2017;  32(5): 1439 –42.
L1183| 8. Oliver D, Griffiths R, Roche J, Sahota O. Hip fracture. BMJ Clin Evid. 2010;2010:1110 .
L1184| Joint Surgery
L1185| © 2023 Carelon Medical Benefits Management. All rights reserved .  33 Codes
L1186| The following code list is not meant to be all -inclusive. Authorization requirements will vary by health plan. P lease consult the
L1187| applicable health plan for guidance on specific procedure codes.
L1188| Specific CPT codes for services should be used when available. Nonspecific or not otherwise classified codes may be subject
L1189| to additional documentation requirements and revi ew.
L1190| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L1191| identify the service or procedure to be performed. If no such code exists, contact the health plan directly and report the se rvice
L1192| or procedure using the appropriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in 99). Do
L1193| not submit a code that is “close to” the procedure performed in lieu of an unlisted code. Correct coding demands that the cod e
L1194| reported is  appropriate for the service provided (i.e., a code that most accurately represents the service provided), and not a
L1195| code that is similar but represents another service. (CPT® Assistant,  December 2010)
L1196| CPT/HCPCS
L1197| CPT® (Current Procedural Terminology) is a r egistered trademark of the American Medical Association (AMA). CPT® five-digit codes,
L1198| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L1199| practice medicine or dispense medi cal services. AMA assumes no liability for the data contained herein or not contained herein.
L1200| 29860  Arthroscopy, hip, diagnostic with or without synovial biopsy (separate procedure)
L1201| 29861  Arthroscopy, hip, surgical; with removal of loose body or foreign body
L1202| 29862  Arthroscopy, hip, surgical; with debridement/shaving of articular cartilage (chondroplasty), abrasion arthroplasty,
L1203| and/or resection of labrum
L1204| 29863  Arthroscopy, hip, surgical; with synovectomy
L1205| 29914  Arthroscopy, hip, surgical; with f emoroplasty (i.e., treatment of cam lesion)
L1206| 29915  Arthroscopy, hip, surgical; with acetabuloplasty (i.e., treatment of pincer lesion)
L1207| 29916  Arthroscopy, hip, surgical; with labral repair [when repair of the labral tear is associated with FAIS]
L1208| Unliste d Procedures
L1209| The following unlisted procedures (CPT 29999 – Unlisted procedure, arthroscopy) are not managed by Carelon
L1210| Medical Benefits Management. Please contact the respective health plan for further assistance.
L1211| • Arthroscopic IT (Iliotibial) band lengthening
L1212| • Arthroscopic repair of gluteus medius or minimus
L1213| • Arthroscopic repair of gluteus medius or minimus (with biologic implant)
L1214| • Arthroscopic trochanteric bursectomy
L1215| Joint Surgery
L1216| © 2023 Carelon Medical Benefits Management. All rights reserved .  34 Knee Arthroplasty (Total/Partial/Revision Knee
L1217| Replacement)
L1218| Description and Scope
L1219| Knee arthroplasty involves removal of some or all of the diseased articular surfaces of the knee, followed by
L1220| resurfacing with metal and polyethylene prosthetic components. Numerous implants composed of various
L1221| biomaterials have been approved by the  U.S. Food and Drug Administration (FDA) for use in knee arthroplasty
L1222| procedures. The goal of the procedure is long -term pain relief and restoration of function.
L1223| This guideline addresses total knee arthroplasty  (TKA), revision TKA, patellar and patella fe moral arthroplasty,
L1224| and unicompartmental knee arthroplasty (UKA) performed as elective, non -emergent  procedures and not as
L1225| part of the care of a congenital condition, acute or traumatic event such as fracture (excluding periprosthetic
L1226| fracture).
L1227| All knee arthroplasties are inclusive of the reattachment of any muscles divided for access to the knee,
L1228| accompanying excision of osteophytes, synovectomy and knee arthrotomy with associated removal of debris.
L1229| Revision knee arthroplasty is inclusive of the exchang e of some or all of the components of a prior knee
L1230| replacement with permanent replacements. It is not inclusive of exchange of components for visualization or joint
L1231| access alone.
L1232| Clinical Indications
L1233| The following general requirements apply to all indicat ions except where they differ from the specific
L1234| requirements. The specific requirements take precedence over any stated general requirement.
L1235| General Information
L1236| The terms in the section provide operational definitions when they are referenced as requiremen ts in the
L1237| guideline.
L1238| Documentation supporting medical necessity and a clearly stated plan of care should be submitted at the time of
L1239| the request and must include the following components:
L1240| Clinical notes  describing symptom duration and severity, specific functional limitations related to symptoms, and
L1241| type and duration of all therapeutic measures provided. If conservative management is not appropriate, the
L1242| reason must be clearly documented.
L1243| Conservative management1 must include a combination of strategies to reduce inflammation, alleviate pain, and
L1244| correct underlying dysfunction, including physical therapy AND  at least ONE  complementary conservative
L1245| treatment strategy.
L1246| • Physical therapy requirement  includes ANY  of the following:
L1247| o Physical therapy rendered by  a qualified provider of physical therapy services
L1248| o Supervised home treatment program that includes ALL of the following:
L1249| ▪ Participation in a patient -specific or tailored program
L1250| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ability to
L1251| perform exercises
L1252| ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L1253| Joint Surgery
L1254| © 2023 Carelon Medical Benefits Management. All rights reserved .  35 o Exception to the physical therapy requirement in unusual circumstances (for inst ance,
L1255| intractable pain so severe that physical therapy is not possible) when clearly documented in the
L1256| medical record
L1257| • Complementary conservative treatment requirement  includes ANY  of the following:
L1258| o Anti-inflammatory medications and analgesics2
L1259| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L1260| o Intra-articular corticosteroid injection(s)2
L1261| o Alternative therapies such as activity modification, and/or a trial period of rest (e.g., from the
L1262| aggravating/contributing factors) , where applicable
L1263| 1 Additional condition or procedure -specific requirements may apply and can be found in the respective sections
L1264| of the guideline.
L1265| 2 In the absence of contraindications
L1266| Clinical reevaluation . In most cases, reevaluation should include a physical examination. Direct contact by other
L1267| methods, such as telephone communication or electronic messaging, may substitute for in -person evaluation
L1268| when circumstances preclude an office visit. Clinical reevaluation must be done in reasonable proximity to the
L1269| anticipated date of service such that the patient’s condition would be unlikely to change by the date of service.
L1270| Failure of conservative management  requires ALL of the following:
L1271| • Patient has completed a full course of conservative management (as de fined above) for the current
L1272| episode of care
L1273| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L1274| • More invasive forms of therapy are being considered
L1275| Documentation of compliance with a plan of therapy that include s elements from these areas is required where
L1276| conservative management is appropriate.
L1277| Reporting symptom severity . Severity of pain and its associated impact on activities of daily living (ADLs) and
L1278| instrumental ADLs (IADLs) are key factors in determining t he need for intervention. For purposes of this guideline,
L1279| significant pain and functional impairment refer to pain rated at least 3 out of 10 in intensity and associated with
L1280| inability to perform at least two (2) ADLs and/or IADLs.
L1281| Imaging reports obtaine d within the past 12 months describing the degree of cartilage damage as determined by
L1282| either or both of the following methods:
L1283| • X-ray report or provider interpretation of x -rays that utilizes or can be correlated with the Kellgren -
L1284| Lawrence grading system o f osteoarthritis
L1285| • MRI report from a radiologist that utilizes or can be correlated with the modified Outerbridge or similar
L1286| classification system related to articular cartilage injury and osteoarthritis
L1287| See Appendix  for a description of these grading systems.
L1288| For x -ray interpretation, the provider shall submit a detailed imaging description that correlates with clinical
L1289| findings of the requested procedure. In the absence of a detailed description , the provider may submit a report
L1290| from an independent radiologist. The results of all imaging studies should correlate with the clinical findings in
L1291| support of the requested procedure.
L1292| For advanced imaging (CT, MRI, ultrasound, bone scan), there must be a report from a radiologist that correlates
L1293| with clinical findings. In the absence of such a report, the summary findings from the radiology report should be
L1294| included in the clinical records .
L1295| Imaging reports should be thorough and describe the presence or absence of subchondral cysts, subchondral
L1296| sclerosis, periarticular osteophytes, joint subluxation, avascular necrosis , or bone on bone articulations. The
L1297| degree of joint space narrowing should also be noted.
L1298| Joint Surgery
L1299| © 2023 Carelon Medical Benefits Management. All rights reserved .  36 General Recommendations
L1300| Tobacco cessation . Adherence to a tobacco cessation program resulting in abstinence from tobacco for at least
L1301| 6 weeks prior to surgery is strongly recommended.
L1302| Diabetes . It is strongly recommended that a patient with a history of diabetes maintain a hemog lobin A1C of 8%
L1303| or less prior to any joint replacement surgery.
L1304| Body mass index (BMI) . It is strongly recommended that a patient with a BMI equal to or greater than 40 attempt
L1305| weight reduction prior to surgery.
L1306| Where there are patient specific modifiable comorbidities that may adversely impact patient reported outcomes or
L1307| the health status of the patient a shared decision -making process with the patient to discuss these modifiable
L1308| comorbidities is strongly recommended and should be documented.
L1309| Total Knee A rthroplasty
L1310| Elective total knee arthroplasty is considered medically necessary for ANY of the following indications:
L1311| • Post-traumatic arthritis
L1312| • Primary or metastatic tumor with limb salvage surgery
L1313| • Unicompartmental, b icompartmental, tricompartmental, or iso lated patellofemoral joint damage or
L1314| destruction due to osteoarthritis, inflammatory disease , avascular necrosis (osteonecrosis) , or other
L1315| chronic conditions when ALL of the following criteria  are met:
L1316| o Imaging evidence of significant joint destruction and cartilage loss, defined as modified
L1317| Outerbridge grade III - IV or Kellgren -Lawrence grade 3 - 4
L1318| o Failure of at least 3 months of non -surgical conservative management (unless radiographs show
L1319| Kellgren -Lawence grade 4)
L1320| o Functional limitation secondary to knee pathology which interferes with the ability to perform  age-
L1321| appropriate daily activities
L1322| See Contraindications .
L1323| Unicompartmental Knee Arthroplasty/Partial Knee Replacement
L1324| Elective m edial or lateral unicompartmental knee arthroplasty (UKA)/partial knee replacement (PKA) is
L1325| considered medically necessary when ALL of the following criteria  are met:
L1326| • Osteoarthritis isolated to the medial or lateral knee compartment with no degenerative changes in the
L1327| opposite compartment
L1328| • Intact anterior cruciate ligament  or documentation of stable knee examination (UKA may done with
L1329| concurrent ACL reconstruction if all other criteria are met)
L1330| • Less than 10 degrees of fixed varus deformity for medial UKA
L1331| • Less than 15 degrees of valgus deformity for lateral UKA
L1332| • Failure of at least 3 months of non -surgical conservative treatments
L1333| • Failure of at least 3 months of non -surgical conservative management (unless radiographs show
L1334| Kellgren -Lawence grade 4 )
L1335| Contraindications
L1336| Medial or lateral UKA is contraindicated when ANY  of the following conditions are present:
L1337| • Inflammatory arthritis
L1338| Joint Surgery
L1339| © 2023 Carelon Medical Benefits Management. All rights reserved .  37 • Moderate -to-severe degenerative changes of the lateral facet of the patellofemoral  joint when considering
L1340| medial compartment replacement ( Kellgren -Lawrence grade 3 or 4)
L1341| • Anterior cruciate ligament deficiency
L1342| • Flexion contracture greater than 15 degrees
L1343| • Fixed varus defo rmity greater than 10 degrees
L1344| • Fixed valgus deformity greater than 15 degrees
L1345| • Flexion less than 110 degrees
L1346| • Previous meniscectomy in another  compartment
L1347| Patellofemoral Arthroplasty
L1348| Elective patellofemoral arthroplasty is considered medically necessary whe n ALL of the following criteria
L1349| are met:
L1350| • ONE  of the following disease states:
L1351| o Advanced symptomatic primary or secondary isolated patellofemoral osteoarthritis (PFOA)
L1352| o Failed extensor mechanism unloading procedures (e.g., lateral retinacular release, recon struction
L1353| of the medal patellar femoral ligament, quadricepsplasty, and bony procedures for realignment
L1354| involving the tibial tuberosity)
L1355| o Symptomatic patellofemoral cartilage defects greater than 4 cm2 after a failed cartilage repair
L1356| procedure, such as autologous chondrocyte implantation (ACI)
L1357| • Failure of at least 3 months of non -surgical conservative management
L1358| • Functional limitation secondary to knee pathology which interferes with the ability to perfor m age-
L1359| appropriate daily activities
L1360| Contraindications
L1361| Patellofemoral arthroplasty is contraindicated when ANY  of the following conditions are present:
L1362| • Tibiofemoral osteoarthritis
L1363| • Inflammatory arthritis
L1364| • Patellofemoral malalignment
L1365| • Knee instability (ligame nts and/or menisci injuries)
L1366| • Limb malalignment (valgus deformity greater than 8 degrees or varus deformity greater than 5 degrees)
L1367| • Fixed flexion contracture greater than 10 degrees
L1368| See Contraindications  including those specific to patellofemoral arthroplasty .
L1369| Primary Hinge Arthroplasty
L1370| Primary hinge arthroplasty is considered medically necessary when ONE of the following criteria are met:
L1371| • Global ligament instability
L1372| • Severe bone loss or deformity
L1373| • Absence or deficit of muscular control
L1374| • Tumoral surgery (bone block resection with ligamentou s insertions needed)
L1375| • Congenital dislocation of knee
L1376| Joint Surgery
L1377| © 2023 Carelon Medical Benefits Management. All rights reserved .  38 • Ankylosis with severe instability after surgical exposition
L1378| See Contraindications .
L1379| Revision of Prior Knee Arthroplasty
L1380| Revision of  prior knee arthroplasty is considered medically necessary when ANY of the following
L1381| conditions are present:
L1382| • Aseptic loosening
L1383| • Substantial osteolysis of the distal femur, proximal tibia, or patella
L1384| • Progressive soft tissue or bone reaction including bearin g surface wear or symptomatic synovitis
L1385| • Component instability, malalignment, failure, or recall
L1386| • Displaced periprosthetic fracture or irreducible dislocation
L1387| • Previous removal of knee prosthesis due to infection or catastrophic failure
L1388| • Reconstruction after treatment of post knee replacement infection
L1389| • Recurrent disabling pain or significant functional disability that persists despite at least 3 months of
L1390| conservative management in conjunction with ANY  of the following:
L1391| o Antalgic gait
L1392| o Abnormal findings confirmed by plain radiography or imaging studies such as implant malposition
L1393| or impingement
L1394| o Knee stiffness  attributable to the prior implants that has failed at least 6 weeks of conservative
L1395| treatment
L1396| See Contraindications .
L1397| Contraindications
L1398| All procedures listed
L1399| • Skin infection at the surgical site
L1400| • Systemic infection
L1401| • Rapidly progressive neurologic disease
L1402| • Extensor mechanism deficiency, not amendable to surgical correction
L1403| • Neuropathic joint
L1404| • Intra-articular corticosteroid injection within the past 6 weeks in the joint being replaced
L1405| Exclusions
L1406| Indications other than those addressed in this guideline are considered not medically necessary  including, but
L1407| not limited to, the following:
L1408| • Bi-unicompartmental knee arthroplasty (medial and lateral tibiofemoral compartments with absence of
L1409| patellofemoral osteoarthritis)
L1410| • Bicompartmental arthroplasty (e.g., medial and patellofemoral compartments of the knee)
L1411| • Focal resurfacing of a single knee joint defect
L1412| • Unicompartmental free -floating (unfixed) interpositional device
L1413| Joint Surgery
L1414| © 2023 Carelon Medical Benefits Management. All rights reserved .  39 Selected References
L1415| 1. American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Knee (Arthroplasty) Evidence -Based Clinical
L1416| Practice Guideline. https://www.aaos.org/oak3cpg Published August 30, 2021.
L1417| 2. Aujla RS, Esler CN. Total Knee Arthroplasty for Osteoarthritis in Patients Less Than Fifty -Five Years of Age: A Systematic
L1418| Review. J Arthroplasty. 2017;32(8):2598 -603.e1.
L1419| 3. Nelson AE, Allen KD, Golightl y YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the
L1420| management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin
L1421| Arthritis Rheum. 2014;43(6):701 -12.
L1422| Codes
L1423| The following code list is not meant to be all -inclusive. Authorization requirements will vary by health plan. Please consult the
L1424| applicable health plan for guidance on specific procedure codes.
L1425| Specific CPT codes for services should be used when available.  Nonspecific or not otherwise classified codes may be subject
L1426| to additional documentation requirements and review.
L1427| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L1428| identify the service or procedure to be performed.  If no such code exists, contact the health plan directly and report the
L1429| service or procedure using the appropriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in
L1430| 99). Do not submit a code that is “close to” the procedure performed in lieu of an unlisted code. Correct coding demands that
L1431| the code reported is appropriate for the service provided (i.e., a code that most accurately represents the service provided) ,
L1432| and not a code that is similar but re presents another service.  (CPT® Assistant,  December 2010)
L1433| CPT/HCPCS
L1434| CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five-digit codes,
L1435| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L1436| practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not co ntained herein.
L1437| 27437  Arthroplasty, patella; without prosthesis
L1438| 27438  Arthroplasty, patella; with prosthesis
L1439| 27440  Arthroplasty, knee; tibial plateau
L1440| 27441  Arthroplasty, knee, tibial plateau; with debridement and partial synovectomy
L1441| 27442  Arthroplasty, femoral condyles or tibial plateau(s), knee
L1442| 27443  Arthroplasty, femoral condyles or tibial plateau(s), knee; with debridement and partial synovectomy
L1443| 27445  Arthroplasty, knee, hinge prosthesis (eg, Walldius type)
L1444| 27446  Arthroplasty, knee, condyle and plateau; medial OR lateral compartment
L1445| 27447  Arthroplasty, knee, condyle and plateau; medial AND lateral compartments with or without patella resurfacing (total
L1446| knee arthroplasty)
L1447| 27486  Revision of total knee arthroplasty,  with or without allograft; 1 component
L1448| 27487  Revision of total knee arthroplasty, with or without allograft; femoral and entire tibial component
L1449| 27488  Removal of prosthesis, including total knee prosthesis, methylmethacrylate with or without insertion o f spacer,
L1450| knee
L1451| Joint Surgery
L1452| © 2023 Carelon Medical Benefits Management. All rights reserved .  40 Knee Arthroscopy and Open Procedures
L1453| Description and Scope
L1454| Knee arthroscopy is a surgical procedure in which a fiberoptic camera is inserted into the knee joint through a
L1455| small incision. In addition to allowing the surgeon to visualize the joint, arthroscopy may also be utilized for
L1456| treatment of a variety of condi tions involving the joint structures.
L1457| This guideline addresses knee arthroscopy when performed as an elective, non -emergent  procedure and not as
L1458| part of the care of an acute fracture.
L1459| Articular cartilage lesions in weight -bearing joints often fail to heal  spontaneously and may be associated with
L1460| pain, loss of function, and long -term complications such as osteoarthritis. A number of surgical techniques have
L1461| been developed to treat these lesions.
L1462| Procedures to treat focal articular cartilage defects can be c lassified as:
L1463| 1. Palliative (lavage, chondroplasty)
L1464| 2. Reparative (microfracture, abrasion arthroplasty)
L1465| 3. Restorative (autologous chondrocyte implantation, osteochondral allograft, or osteochondral autograft)*.
L1466| *See Treatment of Osteochondral Defects
L1467| Chondroplast y or debridement is a smoothing or shaving of symptomatic partial -thickness cartilage lesions or
L1468| chondral flaps (unstable mechanical source of pain).
L1469| Microfracture involves drilling multiple holes through the subchondral bone to promote bleeding and fibroc artilage
L1470| growth.
L1471| Abrasion arthroplasty involves abrading the subchondral bone to the depth necessary to promote bleeding and
L1472| fibrocartilage growth.
L1473| Both microfracture and abrasion arthroplasty are typically performed on lesions less than 4 cm2.
L1474| All arthros copic and open knee procedure codes are inclusive of diagnostic arthroscopy and manipulation under
L1475| anesthesia.
L1476| Clinical Indications
L1477| The following general requirements apply to all indications except where they differ from the specific
L1478| requirements. The spe cific requirements take precedence over any stated general requirement.
L1479| General Information
L1480| The terms in the section provide operational definitions when they are referenced as requirements in the
L1481| guideline.
L1482| Documentation supporting medical necessity and a  clearly stated plan of care should be submitted at the time of
L1483| the request and must include the following components:
L1484| Imaging report . The provider shall submit a detailed imaging report for studies obtained within the past 12
L1485| months that correlates with  clinical findings of the requested procedure. In the absence of a detailed report, the
L1486| provider will be required to submit a report from an independent radiologist. The results of all imaging studies
L1487| should correlate with the clinical findings in support of the requested procedure.
L1488| For x -ray interpretation, the provider shall submit a detailed imaging description that correlates with clinical
L1489| findings of the requested procedure. In the absence of a detailed description, the provider may submit a
L1490| radiologi st’s report.
L1491| Joint Surgery
L1492| © 2023 Carelon Medical Benefits Management. All rights reserved .  41 For advanced imaging (CT, MRI, ultrasound, bone scan), there must be a report from a radiologist that correlates
L1493| with clinical findings. In the absence of such a re port, the summary findings from the radiology report should be
L1494| included in the  clinical records .
L1495| Conservative management . In the majority of cases, a period of conservative management is appropriate prior
L1496| to intervention. Conservative management1 must include a combination of strategies to reduce inflammation,
L1497| alleviate pain, and co rrect underlying dysfunction, including physical therapy AND  at least ONE  complementary
L1498| conservative treatment strategy.
L1499| • Physical therapy requirement  includes ANY  of the following:
L1500| o Physical therapy rendered by a qualified provider of physical therapy services
L1501| o Supervised home treatment program that includes ALL of the following:
L1502| ▪ Participation in a patient -specific or tailored program
L1503| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ability to
L1504| perform exercises
L1505| ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L1506| o Exception to the physical therapy requirement in unusual circumstances (for instance,
L1507| intractable pain so severe that physical therapy is not possible) when clearly documented in t he
L1508| medical record
L1509| • Complementary conservative treatment requirement  includes ANY  of the following:
L1510| o Anti-inflammatory medications and analgesics2
L1511| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L1512| o Intra-articular corticosteroid injection(s)2
L1513| o Alternative therapies such as activity modification, and/or a trial period of rest (e.g., from the
L1514| aggravating/contributing factors), where applicable
L1515| 1 Additional condition or procedure -specific requirements may apply and can be found in th e respective sections
L1516| of the guideline.
L1517| 2 In the absence of contraindications
L1518| Clinical reevaluation . In most cases, reevaluation should include a physical examination. Direct contact by other
L1519| methods, such as telephone communication or electronic messaging , may substitute for in -person evaluation
L1520| when circumstances preclude an office visit. Clinical reevaluation must be done in reasonable proximity to the
L1521| anticipated date of service such that the patient’s condition would be unlikely to change by the date o f service.
L1522| Failure of conservative management  requires ALL of the following:
L1523| • Patient has completed a full course of conservative management (as defined above) for the current
L1524| episode of care
L1525| • Worsening of or no significant improvement in signs and/or sympto ms upon clinical reevaluation
L1526| • More invasive forms of therapy are being considered
L1527| Documentation of compliance with a plan of therapy that includes elements from these areas is required where
L1528| conservative management is appropriate.
L1529| Reporting symptom sever ity. Severity of pain and its associated impact on activities of daily living (ADLs) and
L1530| instrumental ADLs (IADLs) are key factors in determining the need for intervention. For purposes of this guideline,
L1531| significant pain and functional impairment refer to  pain rated at least 3 out of 10 in intensity and associated with
L1532| inability to perform at least two (2) ADLs and/or IADLs.
L1533| Joint Surgery
L1534| © 2023 Carelon Medical Benefits Management. All rights reserved .  42 Knee Arthroscopy /Open Procedures
L1535| Diagnostic arthroscopy
L1536| Diagnostic arthroscopy of the knee joint is considered medically necessary for synovial biopsy or tissue harvest
L1537| (chondrocyte), or when the involved joint meets ALL of the following criteria:
L1538| • Presence of ONE  of the following symptoms
L1539| o Significant pain and functional limitation
L1540| o Instability (e.g., giving way, catching, clicking, locking)
L1541| o Limited range of motion
L1542| • Presence of ONE  of the following physical exam findings
L1543| o Limited range of motion
L1544| o Joint swelling
L1545| o Inconclusive specific diagnostic exam maneuvers
L1546| o Local muscle weakness or atrophy
L1547| • Inconclusive x -ray and/or advanced i maging studies
L1548| • Failure of at least 6 weeks of conservative management
L1549| Exclusion
L1550| In-office diagnostic arthroscopy (e.g., mi -eye 2®)
L1551| Removal of loose body
L1552| Removal of loose body  is considered medically necessary when BOTH  of the following are present:
L1553| • Radiographic evidence of acute, post -traumatic, intra -articular foreign body or displaced fracture fragment
L1554| larger than the size of an arthroscopy cannula (5 mm or larger ) when other knee procedur e codes are
L1555| authorized
L1556| • Knee pain associated with grinding, c atching , or popping
L1557| Exclusion
L1558| Removal of loose body  for Kellgren -Lawrence grade 4  osteoarthritis
L1559| Meniscal repair or meniscectomy
L1560| Acute traumatic meniscal tear
L1561| Meniscal repair or meniscectomy is considered medically necessary for acute traumatic meniscal tear (sudden
L1562| onset of joint -line pain associated with significant knee injury) when ALL of the following requirements are met:
L1563| • Knee injury within last 3 months with new onset knee pain
L1564| • Moderate to severe pain associated with functional limitation, which interferes with the ability to perform
L1565| age-appropriate daily activities
L1566| • Symptoms of catching, locking, or instability
L1567| • Physical exam findings * of at least TWO (2)  of the following:
L1568| o Joint  swelling or effusion
L1569| o Positive McMurray or Apley test
L1570| Joint Surgery
L1571| © 2023 Carelon Medical Benefits Management. All rights reserved .  43 o Joint line tenderness
L1572| o Reduced range of motion
L1573| *If there is a planned concurrent ligament reconstruction and documented menisc al tear, physical exam
L1574| findings specific to meniscus  are not necessary.
L1575| • Imaging confirms features of an acute meniscal tear (e.g., root avulsion, longitudinal vertical, radial, flap,
L1576| posterolateral root, bucket handle, posterior horn, and complex tears, or displaced meniscal fragment)
L1577| Partial meniscectomy is considered medica lly necessary for symptomatic tears not amenable to repair, especially
L1578| when the peripheral meniscal rim is intact.
L1579| Meniscal repair is considered medically necessary for symptomatic reducible tears that are peripheral (e.g., near
L1580| the capsular attachment) a nd horizontal or longitudinal in nature.
L1581| Exclusion
L1582| For x -rays with Kellgren -Lawrence  grade 3 or 4 changes and knee pain preceding recent injury , see Chronic
L1583| degenerative menisc al tear.
L1584| Chronic degenerative meniscal tear
L1585| Meniscal repair or meniscectomy is considered medically necessary for chronic degenerative meniscal tear
L1586| (without any history of significant acute trauma) when ALL of the following are present:
L1587| • Physical exa m findings of at least TWO (2)  of the following:
L1588| o Joint swelling or effusion
L1589| o Positive McMurray or Apley test
L1590| o Joint line tenderness
L1591| o Reduced range of motion
L1592| • Persistent or frequent mechanical symptoms (catching, locking, or instability) or failure of conserva tive
L1593| management for at least 3 months
L1594| • Imaging demonstrating a meniscal tear consistent with the clinical presentation
L1595| • X-ray findings demonstrating no more than moderate osteoarthritis as evidenced by imaging showing
L1596| ONE  of the following:
L1597| o Greater than or e qual to 50% joint space preservation (mild to moderate)
L1598| o Less than or equal to grade 2 Kellgren -Lawrence
L1599| o Less than or equal to grade III modified Outerbridge changes
L1600| Chondroplasty/debridement
L1601| Chondroplasty/debridement is considered medically necessary when ALL of the following criteria are met:
L1602| • Pain or mechanical symptoms
L1603| • Partial thickness cartilage lesion or unstable chondral flap documented by MRI
L1604| • Failure to respond to at least a 6 -week cour se of conservative management in the absence of a chondral
L1605| flap
L1606| • Radiographic imaging consistent with Kellgren -Lawrence grade 2 or lower
L1607| Note: Chondroplasty performed along with a meniscectomy in the same knee is considered part of the main
L1608| (meniscectomy) procedure.  Meniscectomy performed along with a chondroplasty in the same knee is considered
L1609| part of the main (chondroplasty) procedure .
L1610| Joint Surgery
L1611| © 2023 Carelon Medical Benefits Management. All rights reserved .  44 Abrasion arthroplasty/microfracture (knee including patella)
L1612| Abrasion arthroplasty/microfracture (knee in cluding patella) is considered medically necessary when ALL of the
L1613| following lesion and joint criteria are met:
L1614| • Absence of “kissing” knee lesions (lesion must be single and involve only one side of the joint)
L1615| • Lesion is largely contained with near normal s urrounding articular cartilage and articulating cartilage.
L1616| • Full-thickness lesion involving a focal, (grade III or IV) isolated defect of the weight -bearing surface
L1617| • Documented minimal to absent degenerative changes in the surrounding articular cartilage (O uterbridge
L1618| grade II or less), and normal -appearing hyaline cartilage surrounding the border of the defect
L1619| • Knee joint is stable, with functionally intact menisci (knee) and ligaments, and has normal alignment
L1620| • Lesion involves a focal, full thickness, (grade III or IV) isolated defect of the weight -bearing surface
L1621| greater than 1 cm2 – 2.5 cm2
L1622| Corrective procedures (e.g., ligament or tendon repair, osteotomy for realignment, meniscal allograft transplant or
L1623| repair) may be performed in combination with, or prior  to, abrasion arthroplasty/microfracture.
L1624| Debridement/drainage/lavage
L1625| Debridement/drainage/lavage is considered medically necessary for ALL of the following conditions:
L1626| • Rheumatoid arthritis with failure of medical management (DMARDs)
L1627| • Septic joint or oste omyelitis
L1628| • Septic prosthetic joint
L1629| • Postoperative arthrofibrosis with limited range of motion and failure of at least 6 weeks of conservative
L1630| management
L1631| Exclusion
L1632| Debridement or lavage for isolated primary diagnosis of osteoarthritis of the knee
L1633| Arthroscopically assisted lysis of adhesions
L1634| Arthroscopically assisted lysis of adhesions is considered medically necessary for post -traumatic, post -surgical, or
L1635| idiopathic stiffness of the knee when ALL of the following criteria are met:
L1636| • Physical exam de monstrates limited range of motion of the knee, defined as less than 105 degrees of
L1637| flexion or a flexion contracture greater than 10 degrees
L1638| • Range of motion of the knee has failed to improve despite 6 weeks of conservative management
L1639| • Failure of prior mani pulation under anesthesia or manipulation under anesthesia is planned concurrently
L1640| Manipulation under anesthesia
L1641| Manipulation under anesthesia (MUA) is considered medically necessary for post -traumatic, post -surgical, or
L1642| idiopathic stiffness of the knee when ALL of the following criteria are met:
L1643| • Physical exam demonstrates limited range of motion of the knee defined as less than 105 degrees of
L1644| flexion or a flexion contracture greater than 10 degrees
L1645| • Range of motion of the knee has failed to improve despit e 6 weeks of conservative management
L1646| Anterolateral ligament reconstruction or extra articular tenodesis
L1647| Reconstruction of the anterolateral ligament or an extra articular tenodesis for knee stability may be required if
L1648| ANY  of the following criteria are met :
L1649| Joint Surgery
L1650| © 2023 Carelon Medical Benefits Management. All rights reserved .  45 • Skeletal immaturity that makes ACL ligament reconstruction not feasible
L1651| • A revision ACL reconstruction is planned
L1652| • Positive pivot shift or other evidence of rotational instability
L1653| • Ligamentous laxity as confirmed by use of Beighton or comparable score
L1654| Anter ior cruciate ligament reconstruction
L1655| Anterior cruciate ligament (ACL) reconstruction  is considered medically necessary  when  ALL of the following
L1656| criteria are met:
L1657| • There is not advanced knee arthritis (Kellgren -Lawrence grade 4 )
L1658| • A diagnosis of ACL tear as established by EITHER  of the following:
L1659| o Exam findings of a positive anterior drawer sign, pivot shift test or Lachman test
L1660| o Report of CT or MRI which demonstrates an ACL tear
L1661| • At least ONE  of the following scenarios is present:
L1662| o ACL tear occurring in conjunction with a meniscal tear or ligamentous injury (i.e., medial or
L1663| posterior collateral ligament, posterior cruciate ligament, or posterolateral corner ligamentous
L1664| injury)
L1665| o The patient is in volved in a physically demanding occupation (e.g., firefighter, law enforcement,
L1666| construction), or regularly engages in activities which include cutting, jumping, and/or pivoting
L1667| (e.g., skiing, basketball, football)
L1668| o Two (2) weeks of conservative care has been tried and failed (e.g., physical therapy, activity
L1669| modification, oral analgesics)
L1670| Posterior cruciate ligament repair or reconstruction
L1671| Posterior cruciate ligament (PCL) repair or reconstruction  is considered medically necessary  when  ALL of
L1672| the following criteria are met:
L1673| • There is not advanced knee arthritis ( Kellgren -Lawrence grade 4 )
L1674| • A diagnosis of PCL tear as established by EITHER  of the following:
L1675| o Exam findings of a positive posterior drawer sign, reversed pivot shift test, or posterior sag sign
L1676| o CT or MRI performed within the past 12 months demonstrating a PCL tear
L1677| • Associated ligamentous injuries (i.e., injury to posterolateral corner of the knee, medial collateral ligament
L1678| tear, ACL tear, avulsion fracture of fibular head or avulsion of the tibia distal to the lateral plateau)
L1679| Posterolateral corner injury
L1680| Posterolateral corner reconstruction is considered medically necessary when ALL of the following criteria are met:
L1681| • Imaging confirmation of injury to the posterolateral structures
L1682| • Exam fi ndings consistent with a posterolateral corner injury
L1683| • Associated ligamentous injuries necessitating treatment
L1684| Collateral  or extra-articular ligament injury
L1685| Collateral or extra -articular ligament reconstruction is considered medically necessary when EITHER  of the
L1686| following criteria are met :
L1687| • Diagnosis of ligament injury by either  of the following with conservative management  for 6 weeks :
L1688| Joint Surgery
L1689| © 2023 Carelon Medical Benefits Management. All rights reserved .  46 o Advanced imaging evidence of a complete tear
L1690| o Physical exam findings consistent with instability due to the ligament injury
L1691| • Associated ligamentous injury treatment
L1692| Patellar compression syndrome (lateral patellofemoral impingement)
L1693| Lateral retinacular release is considered medically necessary when ALL of the following criteria are met:
L1694| • Positive lateral patellar tilt est ablished on imaging (axial view)
L1695| • Failure of at least 6 months of conservative management
L1696| • Radiographic imaging consistent with Kellgren -Lawrence grade 2 or lower patellofemoral osteoarthritis
L1697| • At least ONE  of the following is present:
L1698| o Positive patella glide test
L1699| o Positive patella tilt test
L1700| o Lateral femoral trochlear or lateral patella facet cartilage lesion confirmed by imaging within the
L1701| past 12 months, when symptoms are consistent with a cartilage defect
L1702| Exclusion
L1703| Central or medial tracking of the patella
L1704| Quadricepsplasty
L1705| Quadricepsplasty is considered medically necessary for knee extension contracture secondary to prior
L1706| femur/knee fracture or surgery when ALL of the following criteria are met:
L1707| • Knee flexion  less than 90 degrees
L1708| • Failure of at least 12 weeks of conservative management
L1709| • Failure of an arthroscopic lysis of adhesions
L1710| Distal realignment procedures
L1711| Distal realignment procedures (tibial tubercle transfer) for patellar instability (subluxation/disloca tion) are
L1712| considered medically necessary in skeletally mature patients when ALL of the following criteria are met:
L1713| • Recurrent patellofemoral instability associated with pain that limits function
L1714| • Failure of at least 12 weeks of conservative management that i ncludes physical therapy
L1715| • Radiographic imaging consistent with Kellgren -Lawrence grade 2 or lower patellofemoral osteoarthritis
L1716| • Presence of at least ONE  of the following:
L1717| o Tibial tubercle -trochlear groove (TT -TG) distance > 20 mm
L1718| o Patella alta  (e.g., Caton -Deschamps index > 1.2)
L1719| Medial patellofemoral ligament reconstruction
L1720| Medial patellofemoral ligament (MPFL) reconstruction is considered medically necessary when EITHER  of the
L1721| following apply:
L1722| • Performed in combination with distal realignment for patellofemoral instability
L1723| • ALL of the following criteria are met:
L1724| Joint Surgery
L1725| © 2023 Carelon Medical Benefits Management. All rights reserved .  47 o Recurrent patellofemoral instability associated with pain that limits function  OR Failure of at least 12
L1726| weeks of conservative management
L1727| o Radiographic imaging consistent with Kellgren -Lawrence grade 2 or lower patellofemoral
L1728| osteoarthritis
L1729| o Presence  of tibial tubercle -trochlear groove (TT -TG) distance < 20 mm , normal trochlear morphology ,
L1730| and a bsence of patella alta
L1731| Plica resection
L1732| Plica resection is considered medically necessary when at least TWO of the following (5) are present  AND
L1733| BOTH additional criteria  are met :
L1734| • Anteromedial knee joint line pain, especially at the medial femoral condyle
L1735| • Audible clicking or snap during knee motion – painful arc 30 to 60 degrees
L1736| • Pain with activities: ascending and descending stairs, squatting, rising from a chair, or sitting for extended
L1737| periods
L1738| • Positive Hughston plica test or positive duvet test (duvet between knees for relief)
L1739| • Visible or palpable (tender) plica
L1740| Additional criteria (BOTH are required)
L1741| • Exclusion of other causes of anteromedial knee pain
L1742| • Failure of at least 12 weeks of conservative management
L1743| Excision of popliteal cyst
L1744| Excision of a popliteal cyst is considered medically necessary when the following is present:
L1745| o Posterior knee pain ≥ 4 on the VAS scale of at least 8 weeks’ duration
L1746| Synovectomy (Limited)
L1747| Limited synovial excision is considered medically necessary when  BOTH  of the following criteria are met:
L1748| • EITHER  of the following
L1749| o Imaging confirmation of a primary  localized synovial proliferative process (e.g., Hoffa’s fat pad
L1750| syndrome, plica, post procedure focal synovial hypertrophy)
L1751| o Physical exam findings and/or symptoms correlat e with the synovial proliferative process
L1752| • Documentation of at least 12 weeks of cons ervative management
L1753| Synovectomy  (Extensive)
L1754| Synovectomy is considered medically necessary for ANY  of the following conditions:
L1755| • Rheumatoid arthritis or other chronic inflammatory arthropathies with failure of conservative management
L1756| • Hemophilic joint disease
L1757| • Other diffuse synovial proliferative disorders , such as:
L1758| o Localized pigmented villonodular synovitis
L1759| o Synovial hemangioma
L1760| o Synovial chondromatosis/osteochondromatosis
L1761| o Infecti ous synovitis  (bacterial or fungal septic arthritis)
L1762| Joint Surgery
L1763| © 2023 Carelon Medical Benefits Management. All rights reserved .  48 Repair of osteochondral defec t
L1764| See Treatment of Osteochondral Defects  guideline.
L1765| Exclusions
L1766| Indications other than those addressed in this guideline are considered not medically necessary  including, but
L1767| not limited to, the following:
L1768| • Arthroscopic debridement or lavage for isolated pr imary diagnosis of osteoarthritis of the knee
L1769| • Lateral retinacular release for central or medial tracking of the patella for patellar compression syndrome
L1770| (lateral patellofemoral impingement)
L1771| • Synovectomy for exposure or visualization, or for post traumatic  reactive synovitis
L1772| • Meniscal repair or partial meniscectomy when meniscal tear is associated with Kellgren -Lawrence grade
L1773| ≥ 3 or modified Outerbridge grade > III osteoarthritis of the knee (exception may be granted for patients
L1774| under age 40)
L1775| • Partial menis cectomy for degenerative tears (horizontal cleavage, intrameniscal linear MRI signal
L1776| penetrating one or both surfaces of the meniscus) with no associated mechanical symptoms
L1777| Selected References
L1778| 1. American Academy of Orthopaedic  Surgeons Management of Osteoarthritis of the Knee (NonArthroplasty) Evidence -Based
L1779| Clinical Practice Guideline. https://www.aaos.org/oak3cpg Published August 30, 2021.
L1780| 2. Arthroscopic Debridement of the Knee: An Evidence Update. Ontario health technology ass essment series. 2014;14(13):1 -43.
L1781| 3. Beaufils P, Hulet C, Dhénain M, Nizard R, Nourissat G, Pujol N. Clinical practice guidelines for the management of meniscal
L1782| lesions and isolated lesions of the anterior cruciate ligament of the knee in adults. Orthop Traum atol Surg Res. 2009;95(6):437 -
L1783| 42.
L1784| 4. Brignardello -Petersen R, Guyatt GH, Buchbinder R, Poolman RW, Schandelmaier S, Chang Y, Sadeghirad B, Evaniew N,
L1785| Vandvik PO. Knee arthroscopy versus conservative management in patients with degenerative knee disease: a sys tematic
L1786| review. BMJ Open. 2017;7(5):e016114.
L1787| 5. Katz JN, Wright J, Spindler KP, Mandl LA, Safran -Norton CE, Reinke EK, Levy BA, Wright RW, Jones MH, Martin SD, Marx RG,
L1788| Losina E. Predictors and Outcomes of Crossover to Surgery from Physical Therapy for Menisc al Tear and Osteoarthritis: A
L1789| Randomized Trial Comparing Physical Therapy and Surgery. J Bone Joint Surg Am. 2016;98(22):1890 -6.
L1790| 6. Khan M, Evaniew N, Bedi A, Ayeni OR, Bhandari M. Arthroscopic surgery for degenerative tears of the meniscus: a systematic
L1791| review and meta -analysis. Cmaj. 2014;186(14):1057 -64.
L1792| 7. Monk AP, Davies LJ, Hopewell S, Harris K, Beard DJ, Price AJ. Surgical versus conservative interventions for treating anterio r
L1793| cruciate ligament injuries. Cochrane Database Syst Rev. 2016;4(4):Cd011166.
L1794| 8. Østerås H. A 12 -week medical exercise therapy program leads to significant improvement in knee function after degenerative
L1795| meniscectomy: a randomized controlled trial with one year follow -up. J Bodyw Mov Ther. 2014;18(3):374 -82.
L1796| 9. Papalia R, Osti L, Del Buono A , Denaro V, Maffulli N. Management of combined ACL -MCL tears: a systematic review. Br Med
L1797| Bull. 2010;93:201 -15.
L1798| 10. Petersen W, Achtnich A, Lattermann C, Kopf S. The Treatment of Non -Traumatic Meniscus Lesions. Dtsch Arztebl Int.
L1799| 2015;112(42):705 -13.
L1800| 11. Quinn RHM , J.; Pezold, R. The American Academy of Orthopaedic Surgeons Appropriate Use Criteria for Surgical Management
L1801| of Osteoarthritis of the Knee. J Bone Joint Surg Am. 2017;99(8):697 -9.
L1802| 12. Smith TO, Postle K, Penny F, McNamara I, Mann CJ. Is reconstruction the be st management strategy for anterior cruciate
L1803| ligament rupture? A systematic review and meta -analysis comparing anterior cruciate ligament reconstruction versus non -
L1804| operative treatment. Knee. 2014;21(2):462 -70.
L1805| Codes
L1806| The following code list is not meant to be all -inclusive. Authorization requirements will vary by health plan. Please consult the
L1807| applicable health plan for guidance on specific procedure codes.
L1808| Joint Surgery
L1809| © 2023 Carelon Medical Benefits Management. All rights reserved .  49 Specific CPT codes for services should be used when available. Nonspecific or not otherwise classifie d codes may be subject
L1810| to additional documentation requirements and review.
L1811| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L1812| identify the service or procedure to be performed.  If no such code exists, contact the health plan directly and report the
L1813| service or procedure using the appropriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in
L1814| 99). Do not submit a code that is “close to” the procedure performed in l ieu of an unlisted code. Correct coding demands that
L1815| the code reported is appropriate for the service provided (i.e., a code that most accurately represents the service provided) ,
L1816| and not a code that is similar but represents another service.  (CPT® Assista nt, December 2010)
L1817| CPT/HCPCS
L1818| CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five-digit codes,
L1819| nomenclature and other data are copyright by the American Medical Association. All Rights Reserve d. AMA does not directly or indirectly
L1820| practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herei n.
L1821| 27331  Arthrotomy, knee; including joint exploration, biopsy, or removal of loose or forei gn bodies
L1822| 27332  Arthrotomy, with excision of semilunar cartilage (meniscectomy) knee; medial OR lateral
L1823| 27333  Arthrotomy, with excision of semilunar cartilage (meniscectomy) knee; medial AND lateral
L1824| 27334  Arthrotomy, with synovectomy, knee; anterior OR posterior
L1825| 27335  Arthrotomy, with synovectomy, knee; anterior AND posterior including popliteal area
L1826| 27345  Excision synovial cyst popliteal space
L1827| 27403  Arthrotomy with meniscus repair, knee
L1828| 27405  Repair, primary, torn ligament and/or capsule, knee; collateral
L1829| 27407  Repair, primary, torn ligament and/or capsule, knee; cruciate
L1830| 27409  Repair, primary, torn ligament and/or capsule, knee; collateral and cruciate ligaments
L1831| 27418  Anterior tibial tubercleplasty (eg, Maquet type procedure)
L1832| 27420  Reconstruction of dislocating patella; (eg, Hauser type procedure)
L1833| 27422  Reconstruction of dislocating patella; with extensor realignment and/or muscle advancement or release (eg,
L1834| Campbell, Goldwaite type procedure)
L1835| 27424  Reconstruction of dislocat ing patella; with patellectomy
L1836| 27425  Lateral retinacular release, open
L1837| 27427  Ligamentous reconstruction (augmentation), knee; extra -articular
L1838| 27428  Ligamentous reconstruction (augmentation), knee; intra -articular (open)
L1839| 27429  Ligamentous reconstruction (augmentation), knee; intra -articular (open) and extra -articular
L1840| 27430  Quadricepsplasty (eg, Bennett or Thompson type)
L1841| 27570  Manipulation of knee joint under general anesthesia (includes application of traction or other fixation devices)
L1842| 29870  Arthroscopy, knee, diagnostic, with or without synovial biopsy (separate procedure)
L1843| 29871  Arthroscopy, knee, surgical; for infection, lavage and drainage
L1844| 29873  Arthroscopy, knee, surgical; with lateral release
L1845| 29874  Arthroscopy, knee, surgical; for removal of loose body or foreign body (eg, osteochondritis dissecans
L1846| fragmentation, chondral fragmentation)
L1847| 29875  Arthroscopy, knee, surgical; synovectomy, limited (eg, plica or shelf resection) (separate procedure)
L1848| 29876  Arthroscopy, knee,  surgical; synovectomy, major, 2 or more compartments (eg, medial or lateral)
L1849| 29877  Arthroscopy, knee, surgical; debridement/shaving of articular cartilage (chondroplasty)
L1850| 29879  Arthroscopy, knee, surgical; abrasion arthroplasty (includes chondroplasty where necessary) or multiple drilling or
L1851| microfracture
L1852| 29880  Arthroscopy, knee, surgical; with meniscectomy (medial AND lateral, including any meniscal shaving) including
L1853| debridement/shaving of articular cartilage (chondroplasty), same or se parate compartment(s), when performed
L1854| 29881  Arthroscopy, knee, surgical; with meniscectomy (medial OR lateral, including any meniscal shaving) including
L1855| debridement/shaving of articular cartilage (chondroplasty), same or separate compartment(s), when perf ormed
L1856| 29882  Arthroscopy, knee, surgical; with meniscus repair (medial OR lateral)
L1857| 29883  Arthroscopy, knee, surgical; with meniscus repair (medial AND lateral)
L1858| Joint Surgery
L1859| © 2023 Carelon Medical Benefits Management. All rights reserved .  50 29884  Arthroscopy, knee, surgical; with lysis of adhesions, with or without manipulation (sepa rate procedure)
L1860| 29885  Arthroscopy, knee, surgical; drilling for osteochondritis dissecans with bone grafting, with or without internal
L1861| fixation (including debridement of base of lesion)
L1862| 29886  Arthroscopy, knee, surgical; drilling for intact osteochondritis dissecans lesion
L1863| 29887  Arthroscopy, knee, surgical; drilling for intact osteochondritis dissecans lesion with internal fixation
L1864| 29888  Arthroscopically aided anterior cruciate ligament repair/augmentation or reconstruction
L1865| 29889  Arthrosco pically aided posterior cruciate ligament repair/augmentation or reconstruction
L1866| G0289  Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage
L1867| (chondroplasty) at the time of other surgical knee arthr oscopy in a different compartment of the same knee
L1868| Joint Surgery
L1869| © 2023 Carelon Medical Benefits Management. All rights reserved .  51 Meniscal Allograft Transplantation of the Knee
L1870| Description
L1871| Meniscal allograft transplantation of the knee is a surgical procedure used to restore normal meniscal function by
L1872| replacing a damaged or absent meniscus with donor cadaver allograft cartilage. The procedure is an option for a
L1873| subset of patients who have p ain or disability attributed to insufficient cushioning and lubrication of the joint.
L1874| A significant subset of these patients have undergone one or more procedures to remove portions of the
L1875| meniscus due to tears or other injury. The goal of the procedure i s reduction in pain, prevention of degenerative
L1876| changes to the cartilage and subchondral bone, and restoration of the mechanical properties of the knee joint.
L1877| Clinical Indications
L1878| The following general requirements apply to all indications except where th ey differ from the specific
L1879| requirements. The specific requirements take precedence over any stated general requirement.
L1880| General Information
L1881| The terms in the section provide operational definitions when they are referenced as requirements in the
L1882| guideline.
L1883| Documentation supporting medical necessity and a clearly stated plan of care should be submitted at the time of
L1884| the request and must include the following components:
L1885| Operative report of a prior arthroscopic procedure and/or MRI of the knee performed wit hin the past 12
L1886| months . The provider shall submit a detailed imaging report that correlates with clinical findings of the requested
L1887| procedure. In the absence of a detailed report, the provider will be required to submit a report from an
L1888| independent radiolo gist. The results of all imaging studies should correlate with the clinical findings in support of
L1889| the requested procedure.
L1890| Conservative management1 must include a combination of strategies to reduce inflammation, alleviate pain, and
L1891| correct underlying dys function, including physical therapy AND  at least ONE  complementary conservative
L1892| treatment strategy.
L1893| • Physical therapy requirement  includes ANY  of the following:
L1894| o Physical therapy rendered by a qualified provider of physical therapy services
L1895| o Supervised home treatment program which includes flexibility and muscle strengthening
L1896| exercises that includes ALL of the following:
L1897| ▪ Participation in a patient -specific or tailored program
L1898| ▪ Initial active instruction by MD/DO/PT with redemonstration of patie nt ability to perform
L1899| exercises
L1900| ▪ Compliance (documented or by clinician attestation on follow -up evaluation)
L1901| o Exception to the physical therapy requirement in unusual circumstances (for instance
L1902| intractable pain so severe that physical therapy is not possibl e) when clearly documented in the
L1903| medical record
L1904| • Complementary conservative treatment requirement  includes ANY  of the following:
L1905| o Anti-inflammatory medications and analgesics2
L1906| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L1907| o Intra-articular corticosteroid injection(s)2
L1908| Joint Surgery
L1909| © 2023 Carelon Medical Benefits Management. All rights reserved .  52 o Alternative therapies such as activity modification, and/or a trial period of rest (e.g., from the
L1910| aggravating/contributing factors), where applicable
L1911| 1 Additional condition or procedure -specific requirements may  apply and can be found in the respective sections
L1912| of the guideline.
L1913| 2 In the absence of contraindications
L1914| Clinical reevaluation . In most cases, reevaluation should include a physical examination. Direct contact by other
L1915| methods, such as telephone communic ation or electronic messaging, may substitute for in -person evaluation
L1916| when circumstances preclude an office visit. Clinical reevaluation must be done in reasonable proximity to the
L1917| anticipated date of service such that the patient’s condition would be unl ikely to change by the date of service.
L1918| Failure of conservative management  requires ALL of the following:
L1919| • Patient has completed a full course of conservative management (as defined above) for the current
L1920| episode of care
L1921| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L1922| • More invasive forms of therapy are being considered
L1923| Documentation of compliance with a plan of therapy that includes elements from these areas is required where
L1924| conservative management is appropriate.
L1925| Reporting symptom severity . Severity of pain and its associated impact on activities of daily living (ADLs) and
L1926| instrumental ADLs (IADLs) are key factors in determining the need for intervention. For purposes of th is guideline,
L1927| significant pain and functional impairment refer to pain rated at least 3 out of 10 in intensity and associated with
L1928| inability to perform at least two (2) ADLs and/or IADLs.
L1929| Meniscal Allograft Transplantation of the Knee
L1930| Meniscal allograft t ransplantation of the knee is considered medically necessary as a treatment for individuals
L1931| with significant partial (more than 50%) or complete loss of the meniscus, as documented by previous operative
L1932| reports, MRI, or diagnostic arthroscopy, when ALL of the following criteria are met:
L1933| • Age 55 or younger and skeletally mature
L1934| • Knee pain refractory to conservative treatment
L1935| • Ligamentous stability either prior to surgery or achieved concurrently with meniscal transplantation
L1936| • Normal alignment without varus or va lgus deformities
L1937| • Mild to moderate articular damage (Outerbridge grade II or less)
L1938| Exclusions
L1939| Indications other than those addressed in this guideline are considered not medically necessary  including, but
L1940| not limited to, the following:
L1941| • Treatment for asympto matic individuals with partial or complete loss of the meniscus
L1942| • Use of other meniscal implants incorporating materials such as collagen and polyurethane
L1943| Selected References
L1944| 1. Beaufils P, Hulet C, Dhénain M, Nizard R, Nourissat G, Pujol N. Clinical practice g uidelines for the management of meniscal
L1945| lesions and isolated lesions of the anterior cruciate ligament of the knee in adults. Orthop Traumatol Surg Res. 2009;95(6):4 37-
L1946| 42.
L1947| 2. De Bruycker M, Verdonk PCM, Verdonk RC. Meniscal allograft transplantation: a meta -analysis. Sicot -J. 2017;3:33.
L1948| Joint Surgery
L1949| © 2023 Carelon Medical Benefits Management. All rights reserved .  53 3. Quinn RHM, J.; Pezold, R. The American Academy of Orthopaedic Surgeons Appropriate Use Criteria for Surgical Management
L1950| of Osteoarthritis of the Knee. J Bone Joint Surg Am. 2017;99(8):697 -9.
L1951| Codes
L1952| The following code list is no t meant to be all -inclusive. Authorization requirements will vary by health plan. Please consult the
L1953| applicable health plan for guidance on specific procedure codes.
L1954| Specific CPT codes for services should be used when available. Nonspecific or not otherwis e classified codes may be subject
L1955| to additional documentation requirements and review.
L1956| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L1957| identify the service or procedure to be performed.  If no such code exists, contact the health plan directly and report the
L1958| service or procedure using the appropriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in
L1959| 99). Do not submit a code that is “close to” the procedure per formed in lieu of an unlisted code. Correct coding demands that
L1960| the code reported is appropriate for the service provided (i.e., a code that most accurately represents the service provided) ,
L1961| and not a code that is similar but represents another service.  (CPT® Assistant,  December 2010)
L1962| CPT/HCPCS
L1963| CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five-digit codes,
L1964| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L1965| practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not co ntained herein.
L1966| 29868  Arthroscopy, knee, surgical; meniscal transplantation (includes arthrotomy for meniscal insertion), medial or lateral
L1967| G0428  Collagen meniscus implant procedure for filling meniscal defects (eg, CMI, collagen scaffold, Menaflex)
L1968| Joint Surgery
L1969| © 2023 Carelon Medical Benefits Management. All rights reserved .  54  Osteochondral Grafts
L1970| Description and Scope
L1971| Articular cartilage lesions in weight -bearing joints often fail to heal spontaneously and may be associated with
L1972| pain, loss of function, and long -term complications such as osteoarthritis. A number of surgical te chniques have
L1973| been developed to treat these lesions, but an established therapy with long -term efficacy remains elusive.
L1974| Procedures to treat focal articular cartilage defects can be classified as:
L1975| 1. Palliative (lavage, chondroplasty)
L1976| 2. Reparative (microfractur e, abrasion arthroplasty)
L1977| 3. Restorative (autologous chondrocyte implantation, osteochondral allograft, or osteochondral autograft)*
L1978| The most widely used are bone marrow stimulation techniques to induce an influx of mesenchymal stem cells into
L1979| the defect.
L1980| Chondroplasty or debridement is a smoothing or shaving of symptomatic partial -thickness cartilage lesions or
L1981| chondral flaps (unstable mechanical source of pain). See knee arthroscopy section.
L1982| Microfracture involves drilling multiple holes through the subc hondral bone to promote bleeding and fibrocartilage
L1983| growth. See knee arthroscopy section.
L1984| Abrasion arthroplasty involves abrading the subchondral bone to the depth necessary to promote bleeding and
L1985| fibrocartilage growth. See Knee Arthroscopy  section.
L1986| Both microfracture and abrasion arthroplasty are typically performed on lesions less than 4 cm2.
L1987| Other techniques involve transplantation of osteochondral tissue from non -weight bearin g sites, autologous
L1988| chrondrocyte transplant, and use of synthetic bone filler material or scaffolds.
L1989| This guideline addresses treatment of osteochondral defects of the knee, ankle, and other joints using the
L1990| following procedures or devices:
L1991| • Autologous cho ndrocyte transplant (ACT)
L1992| • Minced cartilage repair
L1993| • Osteochondral allograft
L1994| • Osteochondral autograft (OATS/mosaicplasty)
L1995| • Resorbable synthetic bone filler materials
L1996| • Microfracture
L1997| Clinical Indications
L1998| The following general requirements apply to all indication s except where they differ from the specific
L1999| requirements. The specific requirements take precedence over any stated general requirement.
L2000| General Information
L2001| The terms in the section provide operational definitions when they are referenced as requirements  in the
L2002| guideline.
L2003| Documentation supporting medical necessity and a clearly stated plan of care should be submitted at the time of
L2004| the request and must include the following components:
L2005| Joint Surgery
L2006| © 2023 Carelon Medical Benefits Management. All rights reserved .  55 Operative report of a prior arthroscopic procedure and/or MRI of the knee performed within the past 12
L2007| months . The provider shall submit a detailed imaging report that correlates with clinical findings of the requested
L2008| procedure. In the absence of a detailed report, the provider will be required to submit a report from an
L2009| independent radiologist. The results of all imaging studies should correlate with the clinical findings in support of
L2010| the requested procedure.
L2011| Conservative management1 must include a combination of strategies to reduce inflammation, alleviate pain, and
L2012| correct underlying dysfunction, including physical therapy AND  at least ONE  complementary conservative
L2013| treatment strategy.
L2014| • Physical therapy requirement  includes ANY  of the following:
L2015| o Physical therapy rendered by a qualified provider of physical therapy servic es
L2016| o Supervised home treatment program that includes ALL of the following:
L2017| ▪ Participation in a patient -specific or tailored program
L2018| ▪ Initial active instruction by MD/DO/PT with redemonstration of patient ability to perform
L2019| exercises
L2020| ▪ Compliance (documented or b y clinician attestation on follow -up evaluation)
L2021| o Exception to the physical therapy requirement in unusual circumstances (for instance,
L2022| intractable pain so severe that physical therapy is not possible) when clearly documented in the
L2023| medical record
L2024| • Complementary conservative treatment requirement  includes ANY  of the following:
L2025| o Anti-inflammatory medi cations and analgesics2
L2026| o Adjunctive medications such as nerve membrane stabilizers or muscle relaxants2
L2027| o Intra-articular corticosteroid injection(s)2
L2028| o Alternative therapies such as activity modification, and/or a trial period of rest (e.g., from the
L2029| aggravati ng/contributing factors), where applicable
L2030| 1 Additional condition or procedure -specific requirements may apply and can be found in the respective sections
L2031| of the guideline.
L2032| 2 In the absence of contraindications
L2033| Clinical reevaluation . In most cases, reeval uation should include a physical examination. Direct contact by other
L2034| methods, such as telephone communication or electronic messaging, may substitute for in -person evaluation
L2035| when circumstances preclude an office visit. Clinical reevaluation must be done in reasonable proximity to the
L2036| anticipated date of service such that the patient’s condition would be unlikely to change by the date of service.
L2037| Failure of conservative management  requires ALL of the following:
L2038| • Patient has completed a full course of conser vative management (as defined above) for the current
L2039| episode of care
L2040| • Worsening of or no significant improvement in signs and/or symptoms upon clinical reevaluation
L2041| • More invasive forms of therapy are being considered
L2042| Documentation of compliance with a plan  of therapy that includes elements from these areas is required where
L2043| conservative management is appropriate.
L2044| Reporting symptom severity . Severity of pain and its associated impact on activities of daily living (ADLs) and
L2045| instrumental ADLs (IADLs) are key  factors in determining the need for intervention. For purposes of this guideline,
L2046| significant pain and functional impairment refer to pain rated at least 3 out of 10 in intensity and associated with
L2047| inability to perform at least two (2) ADLs and/or IADLs.
L2048| Joint Surgery
L2049| © 2023 Carelon Medical Benefits Management. All rights reserved .  56 Patient Selection Requirements
L2050| Candidates for procedures included in this guideline must meet ALL of the following requirements:
L2051| • Skeletal maturity as documented by closure of growth plates
L2052| • Disabling localized knee or ankle pain for at least 3 months, whi ch has failed to respond to at least 6
L2053| weeks of conservative treatment , unless a symptomatic loose body  is present
L2054| • Absence of localized or systemic infection
L2055| • No history of cancer in the bones, cartilage, fat or muscle of the affected limb
L2056| • Willingness and a bility to comply with post -operative weight -bearing restrictions and rehabilitation
L2057| ALL of the following lesion and joint characteristics must be present:
L2058| • Lesion is discrete, single, and involves only one side of the joint
L2059| • Lesion is largely contained with near normal surrounding articular cartilage and articulating cartilage
L2060| • Joint space is normal without evidence of inflammation or degenerative changes
L2061| • Knee or ankle joint is stable with functionally intact menisci (knee) an d ligaments, and normal alignment
L2062| Corrective procedures (e.g., ligament or tendon repair, osteotomy for realignment, meniscal allograft transplant or
L2063| repair) may be performed in combination with, or prior to, transplantation.
L2064| Osteochondritis Dissecans (Juv enile and Adult)
L2065| Osteochondritis dissecans (OCD) is a distinct condition that develops primarily in children and adolescents. A
L2066| focal area of ischemia in the bone results in a progressive separation of a small segment of bone and overlying
L2067| cartilage. OCD a ffects the medial or lateral femoral condyles (not the patella, femoral trochlea, or tibial plateau)
L2068| (AAOS AUC). OCD is usually regarded as either juvenile OCD (JOCD) (occurring with an open epiphyseal plate)
L2069| or adult OCD (AOCD) (after the physis has close d). The etiology of OCD lesions remains unclear and is
L2070| characterized by an aseptic necrosis in the subchondral bone area. OCD is not associated with acute trauma.
L2071| Juvenile OCD
L2072| Surgical treatment (e.g., microfracture, pin fixation) is considered medically n ecessary when BOTH  of the
L2073| following criteria are met :
L2074| • Failure of 3 months of conservative management (e.g., immobilization, restricted weight -bearing,
L2075| avoidance of sports activities)
L2076| • Presence of an unstable lesion (based on advanced imaging or arthroscopic  evaluation)
L2077| Adult OCD
L2078| Surgical treatment (e.g., microfracture, pin fixation, osteochondral graft) is considered medically necessary when
L2079| BOTH  of the following criteria are met :
L2080| • Failure of 3 months of conservative management (e.g., immobilization, restrict ed weight -bearing,
L2081| avoidance of sports activities)
L2082| • Presence of an unstable lesion (based on advanced imaging or arthroscopic evaluation)
L2083| Joint Surgery
L2084| © 2023 Carelon Medical Benefits Management. All rights reserved .  57 Osteochondral Allograft Transplantation
L2085| Cartilaginous defects of the knee
L2086| Osteochondral allograft transplantation to t reat cartilaginous defects of the knee is considered medically
L2087| necessary when BOTH  of the following criteria are met:
L2088| • Size of the cartilage defect is greater than or equal to 1.0 cm2 in total area, as documented by MRI or
L2089| arthroscopy
L2090| • Condition involves a f ocal, full thickness, (grade III or IV) isolated defect of the weight -bearing surface of
L2091| the medial or lateral femoral condyles or trochlear region (trochlear groove of the femur)
L2092| Cartilaginous defects of the talus
L2093| Osteochondral allograft transplantation t o treat cartilaginous defects of the talus is considered medically
L2094| necessary when EITHER  of the following criteria are met:
L2095| • Large (area > 1. 0 cm2) or cystic (volume > 3.0 cm3) osteochondral lesions of the talus when autografting
L2096| would be inadequate due to lesion size, depth, or location
L2097| • Revision surgery after failed prior marrow stimulation for large (area > 1. 0 cm2) or cystic (volume > 3.0
L2098| cm3) osteochondral lesions of the talus when autografting would be inadequate due to lesion size, depth,
L2099| or location
L2100| Osteochondral Autograft Transplantation
L2101| Cartilaginous defects of the knee
L2102| Osteochondral autograft transplantation, either osteochondral autograft transplant (OAT) or autologous
L2103| mosaicplasty, is considered medically necessary to tr eat cartilaginous defects of the knee when ALL of the
L2104| following criteria are met:
L2105| • Size of the cartilage defect is between 1.0 cm and 2.5 cm2 in total area, as documented by MRI or
L2106| arthroscopy
L2107| • Condition involves a focal, full thickness, (grade III or IV) is olated defect of the knee involving the weight
L2108| bearing surface of the medial or lateral femoral condyles or trochlear region (trochlear groove of the
L2109| femur)
L2110| • Absence of “kissing” knee lesions (lesion must be single and involve only one side of the joint)
L2111| Cartilaginous defects of the talus
L2112| Osteochondral autograft transplantation or microfracture, either osteochondral autograft transplant (OAT) or
L2113| autologous mosaicplasty, is considered medically necessary to treat cartilaginous defects of the talus when
L2114| EITH ER of the following criteria is met:
L2115| • Large (area > 1. 0 cm2) or cystic (volume > 3.0 cm3) osteochondral lesions of the talus
L2116| • Revision surgery after failed marrow stimulation for osteochondral lesions of the talus
L2117| Autologous Chondrocyte Implantation
L2118| Cartilag inous defects of the knee/patella
L2119| Autologous chondrocyte implantation (ACI) is considered medically necessary to treat cartilaginous defects of the
L2120| knee/patella when ALL of the following criteria are met:
L2121| Joint Surgery
L2122| © 2023 Carelon Medical Benefits Management. All rights reserved .  58 • Primary chondral defect is present or prior surgica l procedure failed to correct the defect
L2123| • Size of the cartilage defect is greater than or equal to 1.5 cm2 in total area, as documented by MRI or
L2124| arthroscopy  (defects greater than 7 cm2 may require more than one vial)
L2125| • Condition involves a focal, full thickn ess, (grade III or IV) isolated unipolar defect of the knee involving the
L2126| weight bearing surface of the medial or lateral femoral condyles or patellofemoral region (includes
L2127| trochlear region, trochlear groove, and patella)
L2128| • Defect involves only the cartila ge and not the subchondral bone. (Exception to this requirement :
L2129| treatment of osteochondritis dissecans [OCD] associated with a bony defect of 10 mm or less in depth,
L2130| which has failed prior conservative treatment. OCD lesions associated with a bony lesion greater than 10
L2131| mm in depth must also undergo corrective bone grafting).
L2132| • Documented minimal to absent degenerative changes in the surrounding articular cartilage (Outerbridge
L2133| grade II or less), and normal -appearing hyaline cartilage surrounding the border of the defect
L2134| • Normal knee biomechanics or alignment and stability achieved concurrently with autologous chondrocyte
L2135| implantation (ACI).
L2136| Contraindications
L2137| All procedures listed
L2138| • Known allergy to gentamicin or other aminoglycosides
L2139| • Known sensitivity to porci ne or bovine cultures
L2140| • Severe osteoarthritis of the knee (Kellgren -Lawrence grade 3 or 4)
L2141| • Inflammatory arthritis, inflammatory joint disease, or uncorrected congenital blood coagulation disorders.
L2142| • Knee surgery within the previous 6 months (except surgery to procure a biopsy or a concomitant
L2143| procedure to prepare the knee for a MACI implant)
L2144| • Inability to cooperate with a physician -prescribed post -surgical rehabilitation program
L2145| Exclusions
L2146| Indications other than those addressed in this guideline are c onsidered not medically necessary  including, but
L2147| not limited to, the following:
L2148| • Use of non -autologous mosaicplasty with resorbable synthetic bone filler materials including, but not
L2149| limited to, plugs and granules to repair osteochondral defects of the knee  or ankle
L2150| • Use of minced articular cartilage (whether synthetic, allograft or autograft) to repair osteochondral defects
L2151| of the knee or ankle
L2152| • Use of decellularized osteochondral allograft plugs (e.g., Chondrofix®) or reduced osteochondral allograft
L2153| discs (e.g., ProChondrix®, Cartiform®) to repair osteochondral defects of the knee or ankle
L2154| • Use of autologous chondrocyte implantation (ACI) in joints other than the knee (investigational)
L2155| • Allografts preserved by nonstandard tissue bank methods (e.g., Missouri O steochondral Allograft
L2156| Preservation System)
L2157| • Use of larger allografts that involve removing and replacing half or more of the articular surfaces of the
L2158| knee as an alternative to traditional total joint replacement  (e.g., hemi condylar or total condylar for
L2159| degenerative conditions)
L2160| Joint Surgery
L2161| © 2023 Carelon Medical Benefits Management. All rights reserved .  59 Selected References
L2162| 1. Chambers HG, Shea KG, Carey JL. AAOS Clinical Practice Guideline: diagnosis and treatment of osteochondritis dissecans. J
L2163| Am Acad Orthop Surg. 2011;19(5):307 -9.
L2164| 2. Devitt BM, Bell SW, Webster KE, Feller JA, Whitehead TS. Surgical treatments of cartilage de fects of the knee: Systematic
L2165| review of randomised controlled trials. Knee. 2017;24(3):508 -17.
L2166| 3. DiBartola AC, Wright BM, Magnussen RA, Flanigan DC. Clinical Outcomes After Autologous Chondrocyte Implantation in
L2167| Adolescents' Knees: A Systematic Review. Ar throscopy. 2016;32(9):1905 -16.
L2168| 4. Goyal D, Goyal A, Keyhani S, Lee EH, Hui JH. Evidence -based status of second - and third -generation autologous chondrocyte
L2169| implantation over first generation: a systematic review of level I and II studies. Arthroscopy. 2013 ;29(11):1872 -8.
L2170| 5. Mistry H, Connock M, Pink J, Shyangdan D, Clar C, Royle P, Court R, Biant LC, Metcalfe A, Waugh N. Autologous chondrocyte
L2171| implantation in the knee: systematic review and economic evaluation. Health Technol Assess. 2017;21(6):1 -294.
L2172| 6. Mundi R, Bedi A, Chow L, Crouch S, Simunovic N, Sibilsky Enselman E, Ayeni OR. Cartilage Restoration of the Knee: A
L2173| Systematic Review and Meta -analysis of Level 1 Studies. Am J Sports Med. 2016;44(7):1888 -95.
L2174| 7. Niemeyer P, Laute V, Zinser W, Becher C, Kolom be T, Fay J, Pietsch S, Kuzma T, Widuchowski W, Fickert S. A Prospective,
L2175| Randomized, Open -Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix -Associated
L2176| Autologous Chondrocyte Implantation With Spheroid Technology  Versus Arthroscopic Microfracture for Cartilage Defects of the
L2177| Knee. Orthop. 2019;7(7):2325967119854442.
L2178| Codes
L2179| The following code list is not meant to be all -inclusive. Authorization requirements will vary by health plan. Please consult the
L2180| applicable hea lth plan for guidance on specific procedure codes.
L2181| Specific CPT codes for services should be used when available. Nonspecific or not otherwise classified codes may be subject
L2182| to additional documentation requirements and review.
L2183| Medical necessity reviews are initiated by submitting the correct AMA CPT codes. The submitted codes must accurately
L2184| identify the service or procedure to be performed.  If no such code exists, contact the health plan directly and report the
L2185| service or procedure using the ap propriate unlisted procedure or Not Otherwise Classified (NOC) code (which often end s in
L2186| 99). Do not submit a code that is “close to” the procedure performed in lieu of an unlisted code. Correct coding demands that
L2187| the code reported is appropriate for the service provided (i.e., a code that most accurately represents the service provided),
L2188| and not a code that is similar but represents another service.  (CPT® Assistant,  December 2010)
L2189| CPT/HCPCS
L2190| CPT® (Current Procedural Terminology) is a registered trademark o f the American Medical Association (AMA). CPT® five-digit codes,
L2191| nomenclature and other data are copyright by the American Medical Association. All Rights Reserved. AMA does not directly or indirectly
L2192| practice medicine or dispense medical services. AMA ass umes no liability for the data contained herein or not contained herein.
L2193| 20932  Allograft, includes templating, cutting, placement and internal fixation, when performed; osteoarticular, including
L2194| articular surface and contiguous bone (List separately in add ition to code for primary procedure)
L2195| 20933  Allograft, includes templating, cutting, placement and internal fixation, when performed; hemicortical intercalary,
L2196| partial (ie, hemicylindrical) (List separately in addition to code for primary procedure)
L2197| 20934  Allograft, includes templating, cutting, placement and internal fixation, when performed; intercalary, complete (ie,
L2198| cylindrical) (List separately in addition to code for primary procedure)
L2199| 27412  Autologous chondrocyte implantation, knee
L2200| 27415  Osteoch ondral allograft, knee, open [when specified as osteochondral allograft]
L2201| 27416  Osteochondral autograft(s), knee, open (eg, mosaicplasty) includes harvesting of autograft[s])
L2202| 28446  Open osteochondral autograft, talus (includes obtaining graft[s])
L2203| 29866  Arthroscopy, knee, surgical; osteochondral autograft(s) (eg, mosaicplasty) (includes harvesting of the autograft)
L2204| 29867  Arthroscopy, knee, surgical; osteochondral allograft (eg, mosaicplasty)
L2205| 29879  Arthroscopy, knee, surgical; abrasion  arthroplasty (includes chondroplasty where necessary) or multiple drilling or
L2206| microfracture
L2207| 29892  Arthroscopically aided repair of large osteochondritis dissecans lesion, talar dome fracture, or tibial plafond
L2208| fracture, with or without internal fixation (includes arthroscopy)
L2209| J7330  Autologous cultured chondrocytes, implant
L2210| S2112  Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)
L2211| Joint Surgery
L2212| © 2023 Carelon Medical Benefits Management. All rights reserved .  60 Appendix
L2213| Kellgren -Lawrence grading system for radiographic assessment of cartilage damage
L2214| Grade  Description
L2215| 0 Normal
L2216| 1 Doubtful narrowing of joint space and possible osteophytic lipping
L2217| 2 Definite osteophytes, definite narrowing of joint space
L2218| 3 Moderate multiple osteophytes, definite narrowing of joint space, some sclerosis and possible deformity of
L2219| bone contour
L2220| 4 Large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone contour
L2221| Modified Outerbridge grading system for MRI assessment of cartilage damage
L2222| Grade  Description
L2223| 0 Normal
L2224| I Signal intensity alterations with an intact surface of the articular cartilage compared with the surrounding
L2225| normal cartilage
L2226| II Partial -thickness defect with fissures on the surface that do not reach subchondral bone or exceed 1.5 cm in
L2227| diameter
L2228| III Fissuring to the level of subchondral bone in an area with a diameter more than 1.5 cm
L2229| IV Exposed subchondral bone head
L2230| Tönnis grading system for radiographic assessment of osteoarthritis
L2231| Grade  Description
L2232| 0 No signs of osteoarthritis
L2233| 1 Mild: increased sclerosis, slight narrowing of the joint space, no or slight loss of head sphericity
L2234| 2 Moderate: small cysts, moderate narrowing of the joint space, and moderate loss of head sphericity
L2235| 3 Severe: large cysts, severe narrowing or obliteration of the joint space, severe deformity of the head
L2236| Joint Surgery
L2237| © 2023 Carelon Medical Benefits Management. All rights reserved .  61 History
L2238| Status  Review Date  Effective Date  Action
L2239| Revised  04/12/2023  11/05/2023  Independent Multispecialty Physician Panel (IMPP) review. Multiple joints:
L2240| Added indications for removal of loose body . Added conservative
L2241| management requirement  for synovectomy, and ex clusion for traumatic
L2242| reactive sy novitis ; added indications for limited and extensive
L2243| synovectomy in the knee . Shoulder: Modified  conservative management
L2244| requirement s RCT, adhesive capsulitis, shoulder debridement. Added
L2245| exclusion s for subacromial balloon spacer and shoulder resurfacing .
L2246| Added indications for symptomatic os acromiale and symptomatic
L2247| mechanical impingement . Hip: Added indications for primary partial hip
L2248| arthroplasty and partial /total hip resurfacin g; added exclusion for non -
L2249| intraarticular hip procedures . Knee: Modified conservative management
L2250| requirements for unicompartmental knee arthroplasty . Revision knee
L2251| arthroplasty – added indication for reconstruction after post knee
L2252| replacement infection . Patellar compression syndrome – added exclusion
L2253| for central or medial tracking of the patella . Osteochondral grafts : Revised
L2254| patient selection requirements, added indications and exclusions.  Added
L2255| CPT codes 20932, 20933, 20934; HCPCS  code S2118.  Updated
L2256| references.
L2257| Revised  11/11/2021  09/11/2022  Independent Multispecialty Physician Panel (IMPP) review. For total
L2258| shoulder arthroplasty, added fracture indication and exception for
L2259| Kellgren -Lawence grade 4. For hemiarthroplasty, added indications for
L2260| malignancy of the gle nohumeral joint and for glenohumeral arthritis with
L2261| irreparable rotator cuff tear (exclusion removed). For reverse shoulder
L2262| arthroplasty, added indication for when glenoid bone stock inadequate to
L2263| support prosthesis. For labrum repair, removed requirement that SLAP
L2264| lesion is traumatic on MRI. For adhesive capsulitis, matched
L2265| requirements in knee arthroscopy; reduced timeframe of conservative
L2266| management to 6 weeks post -surgery for lysis of adhesions/capsular
L2267| release and MUA. Added patellofemoral osteoarthrit is as an indication for
L2268| total knee arthroplasty. For knee arthroscopy, new indication for abrasion
L2269| arthroplasty/microfracture; removed 12 -week post -surgery requirement
L2270| for MUA and arthroscopically assisted lysis of adhesions. Added CPT
L2271| code 27345. Removed BMI from patient criteria in treatment of
L2272| osteochondral defects. Added contraindications for autologous
L2273| chondrocyte implantation per MACI package insert. Updated references.
L2274| Revised  12/03/2020  09/12/2021  IMPP review. Aligned conservative care definitions across
L2275| musculoskeletal surgery and extremity imaging guidelines. Added a more
L2276| rigorous definition of the supervised home PT requirement for cervical
L2277| and lumbar surgery, and removed cognitive behavioral the rapy as a
L2278| conservative care modality. New indication for diagnostic shoulder, hip,
L2279| and knee arthroscopy. Removed massive tear as a contraindication for
L2280| rotator cuff repair. Added recurrent subluxation as a new indication for
L2281| capsulorrhaphy. Added new crite ria and removed foreign body criteria for
L2282| synovectomy. New indication for debridement. Removed rotator cuff tear
L2283| as a criterion for tenodesis/tenotomy in select patients. For primary total
L2284| hip arthroplasty and total knee arthroplasty, added an exception to
L2285| conservative management for end -stage osteoarthritis. For hip
L2286| arthroscopy, modified conservative management requirements; added an
L2287| exception to full conservative management based on alpha angle;
L2288| removed age as an exclusion for FAIS but further defined rad iographic
L2289| exclusions. For knee arthroplasty, added degenerative change of the
L2290| patellofemoral joint as a contraindication. For knee arthroscopy, more
L2291| expansive approach to physical exam findings; aligned with criteria for
L2292| MUA; added radiographic criteria fo r distal realignment procedures and
L2293| MPFL reconstruction. New criteria for plica resection.
L2294| Revised  07/08/2020  03/14/2021  IMPP review. For knee arthroscopy and open procedures, added
L2295| indications for quadricepsplasty, distal realignment procedures for patel lar
L2296| instability (subluxation/dislocation), and medial patellofemoral ligament
L2297| Joint Surgery
L2298| © 2023 Carelon Medical Benefits Management. All rights reserved .  62 Status  Review Date  Effective Date  Action
L2299| reconstruction. Added CPT codes 23000, 23020, 27418, 27420, 27422,
L2300| 27424, and 27430.
L2301| Updated  - 01/01/2021  2021 Annual CPT code update: descriptions changed for 23466, 29822,
L2302| and 29823.
L2303| Revised  08/12/2019  05/17/2020  IMPP review. Added steroid injection within the past 6 weeks as a
L2304| contraindication for shoulder and hip arthroplasty. For shoulder
L2305| arthroscopy, added exclusions for xenografts, platelet rich plasma, and
L2306| subacromial decompression, and removed indication for  subacromial
L2307| impingement with rotator cuff tear. Added new labral tear indication for hip
L2308| arthroscopy. For knee arthroscopy, added new chondroplasty indication,
L2309| narrowed use of lateral release to lateral compression as a cause for
L2310| anterior knee pain or cho ndromalacia patella, added conservative
L2311| management and advanced osteoarthritis exclusion for patellar
L2312| compression syndrome. Added CPT codes 27425 and 27570.
L2313| Revised  11/28/2018  06/29/2019  IMPP review. All sections: Clarified conservative management option s
L2314| and removed nicotine -free documentation requirement. For shoulder
L2315| arthroscopy, updated criteria for subacromial impingement syndrome and
L2316| tendinopathy of the long head of the biceps. New indication for
L2317| synovectomy/debridement. Added steroid injection excl usion for shoulder,
L2318| hip, and knee arthroplasty. Updated criteria for primary and revision total
L2319| hip arthroplasty; new guideline for resection arthroplasty. For hip
L2320| arthroscopy, expanded appropriate techniques for FAI surgery to include
L2321| acetabuloplasty and femoroplasty, added radiographic and clinical criteria
L2322| to include FAIS -related symptoms. New guideline for elective
L2323| patellofemoral arthroplasty, and added clinical scenarios for revision of
L2324| prior knee arthroplasty. For knee arthroscopy, changes to meniscal
L2325| repair/meniscectomy, and new guideline for arthroscopically assisted lysis
L2326| of adhesions and manipulation under anesthesia. Meniscal allograft
L2327| transplantation: Added exclusion for collagen meniscal implants. New
L2328| criteria for talar osteochondral defects, al low patellar surface autologous
L2329| chondrocyte implantation, and exclude use of decellularized
L2330| osteochondral allograft plugs and reduced osteochondral allograft discs to
L2331| repair osteochondral defects. Added CPT codes 27120, 27122, 27437,
L2332| 27445, 27488, 28446, 2 9871, and 29892. Added HCPCS code G0428.
L2333| Revised  07/11/2018  03/09/2019  IMPP review. Added the General Clinical Guideline.
L2334| Updated  – 01/01/2019  2019 Annual CPT and HCPCS code updates: added 23700, G0289,
L2335| G0428, J7330, and S2112.
L2336| Created  07/17/2017  11/01/2017  IMPP review. Original effective date.